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Imaging guidance may allow minimally invasive alternatives to open surgical 
exposure.  The inherent vascular and soft-tissue contrast of MRI make it an appealing 
imaging modality to guide cardiovascular interventional procedures where traditional X-
ray is inadequate (no soft-tissue guidance) or undesirable (ionizing radiation exposure in 
pediatric or prolonged procedures).  Advances in real-time MRI have made MRI guided 
procedures a realistic possibility.  The MR environment, however, introduces additional 
challenges to the development of compatible, conspicuous and safe devices.  These 
technical challenges require careful preclinical evaluation of applications for feasibility 
and safety.   
The overall goal of this work was to enable selected MRI-guided cardiovascular 
interventional procedures by creating and testing MR conspicuous devices.  In the first 
part of this work, we describe the development and evaluation of actively visualized 
devices for three distinct MRI-guided interventional procedures.  The active needle 
construction provided distinct tip localization and orientation and positioning of the 
needle shaft with unique imaging signatures.  Device image performance was evaluated 
for signal profiles, contrast, and accuracy and size of the marker signals using 
methodologies developed for a more standardized evaluation.  In one application, a 
loopless antenna incorporated into the delivery cable, with reduced material artifacts, 
provided greater operator confidence for proper cardiac occluder device deployment and 
positioning under MRI.  In another application, MRI guidance using a configurable, 
actively visualized positioning and delivery system enabled MRI-guided transjugular 
intrahepatic portosystemic shunting with an excimer laser.   
xix 

The second aim examined the potential heating associated with using conductive 
devices inside the MR environment, and how to monitor and improve the safety of these 
devices.  Phantom testing demonstrated the relative importance of device positioning 
and the highly interrelated nature of these factors on device heating.  Internal 
temperature monitoring allowed us to efficiently characterize device profiles and enable 
continual temperature monitoring during simulated procedures.  Inner temperature 
measurements consistently exceeded external values.  In vivo and in situ measurements 
demonstrated a 50% reduction of measured heating from blood flow and 
thermoregulation.  We then incorporated this temperature monitoring approach into a 
system to monitor device safety and provide dynamic scanner feedback control in order 
further to assure safe device use.   
In the final part of this work, we demonstrated the ability of MRI guidance 
combined with custom active devices to enable traditional and complex cardiovascular 
access.  Reduced field of view imaging improved MRI-guided jugular access and 
workflow to enable procedures to be performed fully in the MR suite.  The active needle 
decreased the time and needle passes necessary for successful access and image 
guidance helped less experienced operators achieve proficiency on par with more 
experienced ones.  We also demonstrated more novel and complex cardiovascular 
procedures in transabdominal hepatic vascular access and transthoracic direct cardiac 
access, planning the trajectory and performing and monitoring the procedure using MRI 
guidance.   
In summary, this work started with the device design, creation and testing, then 
addressed the safety of these devices, and finally employed these custom devices to 
develop and evaluate novel pre-clinical MRI-guided interventions.  Together this 
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represents a comprehensive approach to help enable novel -guided cardiovascular 







Magnetic resonance imaging (MRI) provides superior soft-tissue visualization 
and functional information without ionizing radiation exposure.  Advances in real-time 
MRI provide such images with little latency and introduce the potential for MRI-guided 
interventions.  Minimally-invasive cardiovascular procedures, to be performed as 
alternatives to surgery, are attractive but push the limits of X-ray guidance, particularly in 
treatments for structural heart disease, occluded or inaccessible vasculature, and 
electrophysiologic disorders.  Real-time MRI offers unique imaging guidance for these 
interventions as well as greater procedural planning and evaluation.   
Commercial devices typically used for procedures under X-ray, however, are 
largely incompatible in the MR environment or lack a distinct appearance during MR 
imaging.  Compatible and clearly visualized devices must be developed to bring 
interventional cardiovascular MRI towards the clinical realm.  With suitable devices in 
hand, clinically-relevant workflows and imaging approaches can be implemented in pre-
clinical investigations to evaluate the feasibility and performance of MRI-guided 






We hypothesized that MRI guidance coupled with clearly visible devices can 
provide the operator with greater information to perform routine and complex 
cardiovascular procedures using endovascular or minimally-invasive approaches.  Our 
long-term aim is to enable clinical implementation of interventional cardiovascular MRI 
in suitable target applications. In this work, our objective was to develop and safely to 






1.3 Specific Aims 
The objective of this proposal was completed through the following specific aims:           
SA 1: Develop and Evaluate Clearly Visualized Devices for MRI-Guided 
Cardiovascular Interventions    
To facilitate MRI-guided interventions, we developed devices with embedded 
radiofrequency coils or antennas which provide unique imaging device signatures 
under MRI.   Loop and loopless coils were incorporated into device designs and 
construction to permit desired MRI visualization while maintaining necessary 
mechanical and operating characteristics for the procedure.  Device performance 
was evaluated first in vitro and then in vivo during iterative deployment in pre-
clinical feasibility experiments of MRI-guided cardiovascular interventions such 
as percutaneous access, vascular interventions, and cardiac device placement.                           
SA 2: Examine Device and Operating Factors for Interventional MRI Safety and 
Implement Improved Testing and Monitoring with Scanner Feedback 
Control to Enhance Safety 
In this aim, we examined the factors influencing radiofrequency induced heating 
in complex devices to develop appropriate device and operational 
considerations.  Phantom testing looked at factors such as system components, 
placement in the phantom and scanner, and imaging parameters.  To gain a 
better understanding of safety during realistic use and contributions of perfusion, 
we assessed device heating during in vivo and in situ animal studies with minimal 
device modification to allow real-time temperature monitoring.  This knowledge 
helped to create more realistic device testing protocols, determine suitable 
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device and working parameters, and ultimately develop a safety monitoring and 
control system. 
SA 3: Combine Conspicuous Devices and Procedure Development in an 
Important Preclinical Application: Real-Time MRI-Guided Cardiovascular 
Access
We developed an imaging and procedural approach for real-time MRI-guided 
vascular access using reduced field of view imaging to permit interventions to be 
performed wholly in the interventional MR suite. Outcomes of procedure 
efficiency were used to compare actively and passively visualized needles and 
varied operator experience during jugular vein access in swine.  We also pursued 
targeted approaches to important alternative cardiovascular access routes such 
as percutaneous transabdominal hepatic vascular access and transthoracic 








2.1 Image-guided cardiovascular interventions 
Reduced invasiveness in mechanical therapies is intended to reduce the danger 
and morbidity of surgical access and exposure, yet accomplish the objectives of surgical 
interventions.  These ongoing trends could enable earlier evaluation and subsequent 
intervention to help reduce patient morbidity and mortality.         
Image guidance for cardiovascular procedures began in the early to mid-1900s to 
gather new anatomic and physiologic cardiovascular data when X-ray was first used for 
confirmation and guidance of cardiac diagnostic catheterizations (1).  X-ray helped 
operators to guide devices such as guidewires and catheters to the heart first for 
physiological (hemodynamic) and anatomic (angiographic) diagnosis and then later for 
treatment using angioplasty, stenting, and other endovascular procedures.  Today, 
diagnostic cardiac catheterizations are routinely performed to gather anatomic and 
physiological cardiovascular information and many catheter-based interventions are 
available.  The patient is subjected, however, to renal toxic dye, while the patient and 
staff are both exposed to ionizing radiation.    


1Selections published in Saikus and Lederman, Interventional Cardiovascular Magnetic 




In addition to coronary and peripheral artery interventional procedures, treating 
more complex conditions like aortic aneurysm disease, valvular disease, and other 
congenital and structural cardiac abnormalities has now become part of some 
interventionists’ repertoire.   For many of these procedures, X-ray fails to provide 
adequate visualization of target structures, monitoring of procedural steps and 
evaluation of outcomes.  While X-ray angiography provides high temporal and spatial 
resolution, it is limited to projection views of vessels or cardiac chambers filled with 
radio-opaque dye, providing little information on critical 3D orientation and relationships 
of soft-tissue entities.  Structures of interest like myocardial tissue, valves, or 
inaccessible or occluded vessels remain nearly invisible.   
To further pursue such procedures with minimally invasive techniques, alternative 
visualization of these anatomic structures and physiologic information is necessary to 
replace surgical exposure.  Substitute imaging technologies can help to determine 
appropriate treatment strategies and provide adequate guidance and monitoring to the 
operator throughout the procedure. 
 
2.2 Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) provides a unique combination of excellent 
soft-tissue contrast, multi-planar views, and functional monitoring capabilities without the 
ionizing radiation exposure associated with X-ray and CT.  Clinical MRI is still a relatively 
young imaging modality but is widely deployed for diagnostic imaging.  MRI has become 
the imaging method of choice for many orthopedic soft tissue conditions and the 
diagnosis and monitoring of neurologic diseases.   
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Cardiac MRI can provide a comprehensive examination of cardiac structure, 
functional parameters such as wall motion, blood flow, myocardial scar, and tissue 
perfusion (2).  In addition, vascular MR imaging with time-of-flight angiography can 
delineate blood vessels without gadolinium-based contrast agents.  Gadolinium can be 
administered to provide improved contrast-enhanced angiograms.  Unlike more static 
targets imaged for orthopedic or neurologic applications, cardiac and respiratory motion 
presents an additional challenge for imaging in the thoracic cavity.      
MRI primarily produces its signal from the behavior of hydrogen protons in 
response to their local electromagnetic environment.  Multispectral MR imaging is 
possible using other resonant nuclei such as sodium or fluorine but far less commonly 
used due to lower available signal levels and specialized hardware requirements.  The 
high static magnetic field, B0, is typically produced by a superconducting electromagnet 
at strengths of 1 Telsa (T), or 10,000 Gauss (Earth’s magnetic field <1 Gauss, standard 
refrigerator or iron magnet ~ 50-100 Gauss).  Permanent magnets are used in some 
systems under 1 Telsa, such as open-magnet configurations, but most clinical scanners 
are closed-bore 1.5T or 3T systems.  The high magnetic field produces a net magnetic 
moment when the small hydrogen nuclei act as magnetic dipoles and align with the field 
typically oriented along longitudinal plane, usually the long-axis of the scanner.   
An electromagnetic transmit coil is use to generate a magnetic field, B1, 
perpendicular to B0 and deposit radiofrequency energy  to excite the nuclei and tip the 
magnetization off the longitudinal axis.   The protons tipped toward the transverse plane 
precess, or rotate, at the Larmour frequency (64 MHz for hydrogen in 1.5T) inducing a 
current in receiver coils which eventually provides the MR signal.  Since B0 is not 
completely homogeneous and there are spin-spin interactions, there is a loss of phase 
coherence in the precessing protons so the signal is referred to as a free induction 
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decay (FID) and loss of the signal typically described by T2 or T2* decay time constants.  
Eventually, the spins will tend to recover to their initial position aligned along B0, a 
process known as relaxation and often measured by T1, or recovery of longitudinal 
magnetization. 
To localize the signal in space and create an image, gradient coils are used to 
provide magnetic field gradients along the in-plane and slice-select orientations.  Slice 
selection generally employs a gradient applied during the RF pulse to selectively excite 
that slice for two-dimensional acquisitions and allows arbitrary slice positioning.  In-plane 
localization is typically provided by frequency and phase encoding in the different 
directions.   Frequency-encoding utilizes the application of a gradient which causes the 
protons to precess at slightly different frequencies depending on the net field they 
experience at their individual spatial locations.  Phase-encoding alters the phase of the 
protons with higher gradients producing larger defined shifts in phase coherence.  
Multiple phase-encoding steps are necessary for localization in the second direction.  
This data is collected in k-space where each point encompasses the signal from the 
entire image field under a given gradient field condition.  This can be converted into 
image space with an inverse Fourier transformation to produce the final MR image.  
  
2.3 Real-time MRI 
While most cardiac MRI involves gated examinations to isolate or resolve cardiac 
or respiratory motion and to enhance signal-to-noise, real-time MRI is of interest for 
patients with irregular rhythms where gating may not be feasible or for rapid imaging 
necessary to guide invasive procedures.   Accurate image acquisition, reconstruction, 
and display with overall short latency times is not a simple feat in MRI but critical for 
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guiding interventions in real-time.  Steady-state free precession (SSFP, often referred to 
as TrueFISP, FIESTA, FFE) is commonly used in cine cardiac imaging and during real-
time iCMR procedures due to its excellent blood to tissue myocardial contrast and 
potential high temporal resolution.  Parallel imaging with multiple receiver coils and 
associated reconstruction to appropriately combine the information from each coil (3-5) 
has enabled rapid imaging acquisition for cardiac and real-time imaging.   Coupled with 
advances in computing power using multiple processors for efficient reconstruction of 
imaging data, real-time MRI is available with image display updates at 10 frames per 
second.  Other imaging operations such as myocardial tagging and blood flow 
visualization are also possible in real-time.   
Custom real-time MRI interfaces reconstruct and display these images and 
accommodate interventional procedures (6,7).  Multiple slices can be acquired and 3D 
viewers can provide the operator relative location and orientation of the different views.  
Prior MR imaging can also be incorporated with individual slices, cine acquisitions, or 
MR angiograms serving as roadmaps within the real-time display to complement the 
constantly updating views.  Several scanner manufacturers also have begun to 
implement their own commercial interfaces.  Foot pedals and other remote controls have 
been employed to give the in-room interventionist control over imaging planes but most 
interventional MRI procedures currently require a second scan operator to alter other 
image acquisition parameters.     
Using cross-sectional rather than projection imaging techniques, quickly locating 
a structure or device can be more difficult if part or all of the device is out of plane.  X-ray 
operators are accustomed to projection views where the entire anatomy or device is 
visible in the field of view irrespective of its position in the third direction.  Independent 
coloring of multiple active device channels and device-only projection views help indicate 
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device position (6).  Several additional algorithms to quickly locate and display active MR 
devices and their 3D positioning and automatically update scan parameters have been 
developed to facilitate this aspect of iMRI procedures (8-10).  Projection tracking 
approaches may also help further clarify passive device positioning (11).  
 
2.4 Interventional Cardiovascular MRI (iCMR) 
iCMR aims to leverage the advantages of MR imaging to enable routine and 
complex cardiovascular interventions with greater anatomic information and without 
ionizing radiation exposure.   There are numerous applications for cardiovascular 
medicine (catheter-based endovascular, structural heart disease, surgery, pediatrics and 
electrophysiology) where MRI-guided procedures could have a significant impact in the 
near-term.   
2.4.1 Catheter-Based Endovascular Interventions 
MRI offers one of the few available means to image vessel lumen and wall 
features in addition to the vascular tree and branching using intrinsic contrast 
mechanisms.  Interest in atheroimaging to evaluate vessel morphology and plaque 
characteristics fueled much of the early work in iCMR.  Kantor et al. first described 
internal receiver coils for high-resolution intracardiac 31P NMR (12).  Others soon 
developed local endovascular coils aimed to image arterial wall composition with 
improved SNR and resolution (13,14).  Flow and motion, however, still remain significant 
challenges to high-resolution MR vessel images with realistic scan times in vivo.            
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Vascular interventions such as angioplasty and stenting under MRI can reduce 
radiation and iodinated contrast exposure compared to X-ray procedures and may allow 
unique monitoring for serious complications such as vessel wall dissection or 
perforation.  Despite a dearth of commercial devices, numerous endovascular 
procedures have been pursued in pre-clinical studies and select clinical 
implementations.    Coronary catheterization and stenting have been performed under 
MRI guidance in healthy animals (15-17), but clinical MRI lacks sufficient spatial or 
temporal resolution to guide meaningful coronary interventional procedures.   
Larger peripheral vessels such as aorta and iliac arteries are more suitable 
targets for MRI-guided procedures.  Iliac angioplasty and stenting was performed in 
early human studies by Manke et al. (18).  Renal artery stenting has been conducted 
solely under MRI in an animal renal stenosis (19).  MRI-directed tubular endografts have 
repaired porcine abdominal aortic aneurysms (20), porcine thoracic aortic dissection (21) 
after distinguishing true- and false-lumens; and stent angioplasty for aortic coarctation 
(22).  A clinical pilot study successfully demonstrated MRI-assisted angioplasty for aortic 
coarctation in combination with X-ray (23).  
2.4.2 Beyond the Vessels  
MRI could allow catheter-based procedures to escape the traditional confines of 
vascular lumens.  Completely occluded vessel segments, such as in chronic total 
occlusions (CTO), are virtually invisible in x-ray angiography where contrast cannot enter 
the obstructed lumen.  MRI guidance will identify the mural contour of the occluded 
vessel and help guide recanalization while avoiding perforation.    Recanalization of an 
animal model carotid CTO using a custom active MRI device was significantly more 
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successful than X-ray guided alternatives (24). Newer devices are being developed that 
clearly indicate the device position during recanalization (25).              
Extra-anatomic bypass, directly connecting two otherwise unconnected vascular 
structures, is a unique application that might be performed without surgery because of 
MRI guidance.  In a hybrid X-ray/MR approach to transjugular intrahepatic portosystemic 
shunt (TIPS) procedures, MRI helped reduce the number of needle passes needed to 
connect the hepatic to portal vein within the liver (26).  Mesocaval puncture is an 
alternative portocaval trajectory enabled by MRI and custom-designed needle devices 
(27).  A non-surgical Blalock-Taussig subclavian-pulmonary shunt is a tantalizing 
potential application of this technology.     
MRI display of critical anatomy may have value for structural heart disease 
interventions.   MRI has guided needle (28) and laser (29) atrial septal puncture and 
delivery of nitinol closure devices for atrial septal defects (30-32) in swine.  MRI may 
enhance positioning (with regard to myocardial fibrous skeleton and coronary arteries) of 
transcatheter (33) and transapical (34)  aortic valve implants in swine, and allows 
immediate evaluation of valve performance and flow.  Hybrid imaging guidance is under 
development using an adjacent “MRI-friendly” X-ray fluoroscope at the edge of the 
magnet (35).     
The development of novel biologic treatments for cardiovascular disease will 
require accurate methods of delivery and following treatment. Procedures targeting soft-
tissue structures like the myocardium for biopsy, local drug delivery, or future gene and 
cellular therapies are performed under X-ray with limited knowledge of the borders of 
cardiac chambers or contours of myocardial targets.  MRI guidance provides not only 
tissue and device visualization for accurate targeting during delivery (36,37), but unique 
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MR contrast mechanisms and additional agents can be incorporated in treatments to 
track their distribution (38).  In preclinical animal studies, several groups have 
demonstrated successful delivery of cell and gene products to myocardial targets (39-
41). 
 
2.4.3 Pediatrics  
Pediatric patients have much to benefit from MR guided interventional 
procedures.  Children with congenital heart disease often require multiple 
catheterizations to monitor physiological parameters and for treatment that might avoid 
or delay open heart surgery.  Each interventional procedure, however, is offset by the 
risk for unobserved complications and possible long-term consequences from x-ray 
exposure.  Children, already more susceptible to radiation exposure, often require 
protracted interventions, increasing potential risk for chromosomal abnormalities and 
carcinogenesis (42).   For medical staff, occupational x-ray exposure risks malignancy 
and cataracts (43) while protective lead garments risk chronic orthopedic injury (44).     
Diagnostic catheterizations and EP procedures have been performed in pediatric 
and adult patients with congenital heart disease using a CO2-filled balloon-tip catheter 
for visualization in a combined MR/X-ray suite (45).  MRI-guided catheterization has 
further provided more accurate assessment of total or split pulmonary vascular 
resistance in patients (46,47).  Beyond diagnostics, MRI might enhance treatment of 
structural pathology in children and adults with congenital heart disease.  Interventions 
for structural abnormalities such as ventricular septal defect (VSD) could benefit from 
improved visualization of the septal defect and close procedural monitoring.  Preclinical 
MRI-guided pulmonary artery and valve stenting (48) suggests percutaneous pulmonary 
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valve replacement (49) might be feasible under MRI.  Most recently, MRI-guided 
pulmonary valve balloon dilatation was reported with 2 clinical cases, one adult and one 
pediatric, using a passively visualized guidewire (50).  Test occlusion of a Fontan repair 
fenestration under real-time MRI has also recently been demonstrated (51).   
 
2.4.4 Electrophysiology 
MRI might offer one-stop visualization of cardiac surfaces being mapped, 
monitoring of ablation, and assessment of ablation lesions.  Compared with ablation 
under direct surgical exposure, catheter ablations of atrial fibrillation or ventricular-
tachycardia are lengthy and complex, most likely because of inadequate targeting and 
visualization of ablation lesions.   MRI might have value beyond the baseline roadmaps 
now widely imported into electroanatomic mapping systems (52).  Of particular appeal is 
the ability to conduct MRI thermometry during myocardial ablation, to determine the 
spatial extent of thermal injury (53), or the ability to assess subacute injury by imaging 
edema or myocardial contrast enhancement (54,55).  MR-compatible cardiac monitoring 
and ablation systems have made MRI-guided EP procedures possible (56-58).  
Recently, initial clinical feasibility of real-time MRI-guided EP studies with cardiac 
mapping was demonstrated in 2 patients (59).   
 
2.5 Multi-modality Guidance 
X-ray combined with MRI, referred to as coregistration or XFM (X-ray fused with 
MRI), overlays previously-acquired MR images to assist interventionists during difficult 
X-ray fluoroscopy procedures.  In this way, procedures enjoy the wide array of X-ray 
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compatible catheter equipment and additional 3D information about target vascular 
structures afforded by prior MRI.  This multi-modality approach has been used clinically 
in high-risk myocardial free wall biopsy (60).  XFM also enabled targeted 
endomyocardial injections (61) and a complex repair of membranous ventricular septal 
defects (VSDs) with significantly decreased fluoroscopy times in pre-clinical animal 
studies (62).   Clinical EP studies have long gleaned valuable information from this 
hybrid approach with MRI roadmaps in electroanatomic mapping systems (52).     
 
2.6 Interventional MRI in Other Clinical Disciplines 
Several other clinical disciplines have embraced interventional MRI to guide 
critical procedures.  Most enjoy targets that are relatively accessible, immobile, or 
require short, straight needle devices.  Neurosurgeons routinely use pre-procedural MRI 
with stereotactic frames for biopsies and resections; many conduct intraoperative MRI to 
guide, for example, tumor margins (63).  Biopsy is also conducted under MRI for 
potential liver, breast, and prostate malignancies (64).  Tumor cryo- and radiofrequency 
ablation benefit from MRI guidance which allows interactive thermal imaging (65).  MRI 
also enhances orthopedic biopsies, injections and other therapies (66).  Many of these 
applications have fueled additional development of local imaging coils and MR-
compatible manipulators and robotics (67). 
 
2.7 Interventional MRI Devices 
The same mechanisms which provide the unique image contrast in MRI also 
make most devices commonly used in X-ray procedures either invisible or unacceptable 
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for use during iCMR procedures.  Metallic cores or braiding present in many devices for 
pushability and torquability can cause imaging artifacts and potentially obscure entire 
anatomic areas.  Purely polymer products aren’t visible unless modified and often lack 
requisite mechanical performance.  Many of the MRI-guided procedures described 
above have used custom devices since MR-compatible commercial device availability is 
limited.  These interventional MRI devices are typically classified by the mechanism by 
which they are visualized in imaging and the need for connection to the scanner 
hardware: Passive, Semi-active, and Active.   Figure 2.7.1 shows an example of the MR 
appearance for each of these different device visualization strategies which are 





Figure 2.7.1 Device appearance in MRI with different visualization strategies: 





2.7.1 Passive Devices  
Passive devices generally rely on material properties to visualize devices during 
MR imaging.  Magnetic susceptibilities, or how the material responds to a magnetic field, 
of various materials can cause small regions of inhomogeneities in the main magnetic 
field producing signal voids appearing as dark regions on images and often referred to 
as negative contrast.   Positive contrast can be generated using agents such as T1 
shortening agents to alter the local signal which will appear brighter than it would 
otherwise.  Many initial passive devices used polymer catheters with ferromagnetic (68) 
or paramagnetic coatings or rings (69,70) to produce negative or positive contrast, 
respectively.  Other catheters with CO2-filled  balloons (71) or filled with more unique 
contrast agents such as 19-F (72) and hyperpolarized 13-C (73) with multi-spectral 
detection have also been explored.  The length of these passive devices can be made 
visible by coating the entire device but a large portion of the catheter volume may be 
occupied by these fillers which are not always readily apparent.  Off-resonance imaging 
techniques (74,75) is attractive to improve the specificity of the signal during imaging but 
can limit anatomic imaging.  Recently, several groups have developed sophisticated 
non-metallic passive guidewires with specially formulated polymers and constructions 
such as micropultrusions to mimic the mechanical properties of their metallic X-ray 
counterparts with thin super paramagnetic iron oxide markings for visualization (76,77).  
These passive approaches avoid many of the RF safety concerns discussed below and 
often provide a simpler approach to device construction.  A key limitation of these 
passive approaches, even using off-resonance imaging techniques, is uniquely 
identifying the device “signature” during imaging.  Uncertainty about device position and 
orientation during MRI-guided procedures, is a critical limitation that impacts safety, 




2.7.2 Active Devices  
Active devices for interventional MRI incorporate small coils or antennas  on 
independent channels connected to the scanner for device tracking (78) or visualization 
to provide clear device identification.  Device tracking requires special tracking 
sequences to locate the tracking coil in 3D space with the device position and path then 
marked on prior or interspersed images.  Active device “imaging” or “profiling” enables 
unique visualization of the device profile on MR images acquired in real-time, in the 
specific context of surrounding anatomy.  Many of the early coil designs for 
atheroimaging evolved into active devices such as catheters and guidewires with loop 
and loopless (79) antenna designs that could be uniquely visualized under MRI and 
used to facilitate iCMR procedures.  It is challenging to incorporate the requisite 
electrical and mechanical components in appropriately-sized designs while maintaining 
the functionality operators expect.     
        
2.7.3 Semi-Active Devices  
Semi-active devices typically contain circuit elements such as inductively-coupled 
resonantors (position markers) that do not require long transmission lines or connection 
to the scanner but may be more visible than passive devices.  Through mutual 
inductance the signal around the inductively-coupled coil can be picked up by the other 
receiver coils.  These markers can be incorporated on the distal end of catheters (80,81) 
but the catheter appearance is then limited to this region.  Further optical tuning (82,83) 
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or signal separation (84) techniques still may be required to firmly distinguish these 
devices from background tissue or artifact.    
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Table 2.7.1  Visualization Methods of Interventional MRI Devices (adapted from (85,86))
Approach Technology Advantages Disadvantages Examples 
Passive 
markings 












Can be used in 
combination with 
other approaches 
Can use imaging 
techniques (“white 









wires can heat 
Must not contain ferrous 
braids 
Cannot automatically 
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the scanner which 




Catheters can be 






Conductive wires can 
heat 
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with X-ray catheters 
Dipole designs have poor 






















sequences for 3D 
location of coil 
Simple, inexpensive 
Marker points can 
be tracked without 
imaging, to 
increase speed or 
reduce heating 
Marker points can 
be used to 
automate scan 
plane adjustments 
No real-time MRI 
Requires specialized 
tracking sequences  
Catheter locations are 
computer-synthesized 
on image 












Resonant RF coil 
coupled to other 
receiver coils 
Requires no physical 
connection 
Reverse polarization 
mode may display 
unique device 
signature 
Embeds electronics that 
might interfere with 
mechanical 
performance (i.e. on 
stents) 
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2.8 MRI Safety 
Each of the electromagnetic fields that enable MR imaging must be considered to 
avoid potential safety risks for procedures and medical devices in the interventional MRI 
environment.  The static magnetic field (B0) can exert tremendous force and torque on 
ferromagnetic objects, drawing them into the bore (89).  As a result, instruments, 
monitoring equipment, and other implements used near MRI scanners must be non-
magnetic or properly labeled and secured to avoid creating dangerous projectiles in the 
room.  Thorough patient screening is a critical component to ensure MRI safety and 
exclude patients that have embedded metal from older implants or exposure to metal 
filings or shrapnel that may be subject to these forces or experience increase RF 
deposition and heating.  The impact of exposure to high magnetic fields, particularly 
regular exposure for staff, has also been debated (90).   
Magnetic field gradients (Gx, Gy, and Gz) for spin localization and the pulsed 
electromagnetic RF field (B1) used to flip the spins down to the transverse plane 
produce rapidly changing electromagnetic fields.  Conductive loops oriented 
perpendicular to pulsed or changing magnetic fields can develop induced currents 
according to Faraday’s law of electromagnetic induction and produce resistive, or Joule, 
heating.  The induced voltage from the time-varying magnetic flux increases with 
increasing loop area, number of loops, and rate of change and strength of the magnetic 
field (Equation 2.8.1).   








Reducing or avoiding induction loop heating is a main rationale behind 
recommendations for patients to avoid crossing arms or legs and for staff to assure 
cables for coils or ECG monitoring do not form loops (91).  A resonant loop can further 
contribute to the heating observed (92).  Non-looped conductors also can experience 
eddy current formation which produces an opposing magnetic field in accordance with 
Lenz’s law in addition to inductive heating.  Current formation increases with increasing 
applied field strengths, conductivity of conductors, and rate of changes of the magnetic 
field.    
Physiologically, the rapid application and switching of magnetic field gradients 
are most commonly associated with patient nerve stimulation which limits the applicable 
slew rate, or rate at which they reach their final value (93).  Cardiac stimulation is 
possible but the threshold is much higher.  Acoustic noise generated by vibration of 
these gradient coils and nearby metallic structures can be reasonably overcome through 
the use of hearing protection and MR-compatible communication systems.   The applied 
high RF transmit power may cause tissue heating due to the induced eddy currents in 
the body (94).  The RF energy is primarily absorbed at the surface where tissue heating 
potential would be highest and minimal towards the center (95).  Specific absorption rate 
(SAR) is the measure typically used to describe the RF power deposited to a mass of 
tissue (in watts/kilogram) and is usually given for whole-body average measurements 
(WB-SAR) but power can locally focused and deposited depending on the environment 
producing SAR hotspots.  Power limitations and FDA guidance for MRI scanning and 
implant compatibility have traditionally considered temperature increases of 1°C in the 
head, 2°C in the trunk, and 3°C in the extremities to not have any expected adverse 
effects in people with normal thermoregulation.  This is largely based on the normal daily 







for heat stroke (41°C) and local heating of >41°C that may cause tissue damage with 
extended (20 min – 1 hour) application (96).   
Conductive implants and devices can focally concentrate the induced electric 
fields and cause local increases in current density and SAR with corresponding tissue or 
phantom heating (97).  The production of standing waves can arise in devices with 
impedance mismatches with reflection at the transition points and constructive addition 
of the induced currents on the conductor.  Devices with lengths near a half-wavelength 
may experience resonant effects and act as linear antennas, coupling with the parallel 
electric field and producing high induced potentials (Equation 2.8.2) and voltage 
dissipation near the device ends and/or interface transitions leading to local SAR 
hotspots and heating (92,98-100).   







          
Several approaches for active devices and implants in MRI have targeted the 
electrical properties or effective electrical length of the transmission lines to reduce 
shield currents and standing waves seen at resonant lengths.   High impedance cables 
can limit the degree of RF current supported.  Quarter-wave coaxial chokes can 
incorporated into coaxial transmission lines to limit shield, or common-mode, currents by 
presenting a high impedance on the outer surface of the conductor without impacting the 
differential-mode signal (101).  Alternatively to incorporating a choke into the cable itself, 
“floating” current traps tuned to the Larmour frequency can be used to minimize shield 
currents (102).  Long dipole antennas utilize 1:1 baluns in accompanying circuitry to 
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produce a high-impedance for the shield currents.  Transformers present yet another 
option to block unwanted shield currents by transmitting signal via inductive coupling and 
breaking up the cable into short non-resonant lengths (103) and have been recently 
incorporated into an active EP catheter with highly resistive wires for the ECG monitoring 
(104).  Additional approaches explored include a Bazooka coil which also inductively 
couples the signal (105) and use of a Q-spoiling dielectric to reduce tip heating (106).  
Many of these approaches, however, have been difficult to incorporate in small devices 
or may cause heating in other device locations.                 
Replacing conductive transmission lines with optical fiber can avoid unwanted 
interactions between the cables and RF electric field.  Optical connections have been 
used previously to selectively detune coils for better localization of inductively coupled 
signals (83).  More recently, an optical transmission system for an active MRI device 
was developed with continued work to appropriately miniaturize the technology for use in 
clinically useful designs (107).  Size restrictions, again, have limited deployment of these 





2.9 Clinical Significance 
Real-time MRI guidance could enhance cardiovascular procedures that are 
currently guided by different imaging modalities, and it could enable novel minimally 
invasive procedures.  Prolonged x-ray exposure, such as during catheter repair of 
congenital heart defects, could be avoided.  Procedures that currently require surgical 
exposure, such as extraanatomic vascular bypass, might be possible with a wholly 
catheter-based approach because of the soft-tissue imaging afforded by MRI.  Imaging 
of tissue, rather than X-ray guided positioning with limited anatomic information, might 
enhance ablation therapy for cardiac rhythm disorders.   Soft-tissue targets can be 
approached with percutaneous approaches with monitoring in multiple views and greater 
anatomic context not currently afforded by ultrasound.  For these procedures ultimately 
to impact patient care, appropriate devices must be available and tested to ensure safety 
and performance and allow development and evaluation of these procedures in pre-
clinical studies.   
This work combined several critical elements to bring MRI-guided cardiovascular 
interventions closer to the clinical realm.   This first aim tackled the unavailability of 
compatible devices for interventional MRI with unique signal profiles which are 
necessary to clearly locate and follow them in real-time MRI guided procedures.  The 
development of devices for several different cardiovascular interventions demonstrated 
how different coil designs and visualization approaches can be leveraged to improve the 
visibility of devices and implants while maintaining the requisite handling for the 
procedure.   
The second aim addressed MRI safety for active device design and use where 
long metallic components or conductors may experience radiofrequency induced heating 
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but studies of complex devices are limited.  Heating studies in the second part of this 
work examined various factors influencing heating and more clinically realistic scenarios 
with correlates between phantom and in vivo testing in large animal models.  This helped 
identify appropriate device and operating parameters to ultimately develop safety 
monitoring approaches for initial clinical testing.   
The final aim addressed direct percutaneous vascular access inside the 
interventional MRI system, which would be an attractive alternative to access in the X-
ray system followed by transfer to the MRI system and permit procedures to be 
performed completely in the MRI suite.  In this aspect of the work, we provided the 
requisite devices, imaging and procedure approaches to enable a pre-clinical evaluation 
for MRI-guided vascular access in swine.  To allow more complex minimally-invasive 
cardiovascular procedures, percutaneous transhepatic vascular access and direct 
transthoracic cardiac access were demonstrated in swine under MRI guidance for 






ACTIVE DEVICE DEVELOPMENT 
3.1 Introduction  
Most devices currently available for limited interventional MRI procedures are 
visualized passively.  Typically they are visible as dark artifacts, or negative contrast, 
due to (a) water displacement, (b) the different magnetic susceptibilities relative to water, 
causing small local inhomogenities in the B0 static magnetic field, and (c) radiofrequency 
(RF) inhomogeneity (108).  These devices can be difficult to clearly identify in imaging as 
other fluctuations in signal intensity, complex anatomic boundaries, and artifacts can 
show similar appearances, particularly in highly dynamic anatomies such as the heart.   
Active devices aim to produce a unique imaging signature by incorporating small 
local coils or antennas  connected to the scanner for device tracking (78) or visualization 
(“profiling”).  While tracking can provide 3D device positioning, it is typically limited to 
small coil locations and requires tracking sequences interleaved with real-time anatomic 
imaging.  Device visualization allows simultaneous display of device positioning and 
shape with real-time imaging and more closely represents the device appearance 
operators have in other modalities.  Cross-sectional imaging techniques, in contrast to 
projection imaging, introduce additional device visualization requirements as the entire 
device profile may not always be in plane or visible.   
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Loop and loopless (79) coil constructions are used for internal coils and active 
visualization techniques which could be incorporated into active device design (Table 
3.1.1).  Loop coils like solenoids typically create more localized signal intensity profiles 
that fall off rapidly from the coil.  Loopless designs which represent a half-dipole antenna 
can provide signal along linear devices but distal signal at the tip typically is limited.  
Combined coil implementations can provide the construction and signal profile 
advantages of both, but may be limited by coupling of the different channels.   
 
Table 3.1.1.  Loop and loopless antenna designs  
 
 
Compact coaxial constructions are possible with loopless constructions where the whip, 
or extended inner conductor, serves as one 	/4 pole of the antenna with the shield of the 




Figure 3.1.1.  Schematic of loopless antenna design.
 
These coil designs represent the inductors in an RLC (resistor-inductor-capacitor) circuit 
tuned to resonate at 64 MHz to receive the signal from the local precessing protons and 
impedance matched for maximum power transfer and minimal reflection (Figure 3.1.2).  
Detuning during transmit occurs with high impedance across a capacitor gap in the loop 
coil and at the junction of a loopless design to prevent coupling to the transmit coil, 
induced current flow from the high applied power and local flip angle amplification.  
 





 Because device size limitations often preclude local tuning and matching of the coil on 
the device body itself, remote matching is usually employed but necessitates small 
transmission lines in the antenna construction which can negatively impact signal 
performance.     
Active device visualization is also unique compared to X-ray devices where the 
device appearance comes from X-ray attenuation.  The local coils in MRI devices 
receive their signal from their local environment and the device construction may also 
impact device and anatomic imaging.   
Considerations for device visualization must be balanced with the mechanical 
properties necessary to accomplish the desire procedure.  Device size cannot be 
dramatically increased to accommodate incorporated coils which would necessitate 
larger access and limit device positioning.  Insulation is critical to protect the coils or 
separate components of the conductive structure.  With the additional layers necessary 
for coil insulation, however, the device may become more rigid.  Material type and 
thickness must also be selected to have adequate pushability for advancement, 
restoring force for deflection and appropriate torquability for rotation.   
In this work, we developed actively visualized devices to enable pre-clinical 
feasibility studies of three MRI-guided cardiovascular interventional procedures.  For 
MRI-guided percutaneous access, an active needle was needed to allow clear tip and 
tract localization.  To facilitate cardiac occluder device delivery under MRI guidance, 
improved visibility of the device deployment was necessary.  In evaluating the use of an 
excimer laser for extra-anatomic bypass such as TIPS, means to direct the laser and 
visualize curvature and trajectories were lacking.  For each of these applications, we 
hypothesized that incorporating active visualization strategies in the device design could 
32 

provide the necessary device appearance for the given procedure while maintaining or 
enhancing the requisite mechanical performance.  We also recognized that methods 
were necessary to evaluate the device imaging performance for a more systematic 





3.2 Active Needle 
For MRI-guided percutaneous procedures, specific tip location is critical as well 
as visualization along the needle.  MRI-compatible needles are available in non-
magnetic metal alloys which are visible under MR due to water displacement and the 
different magnetic susceptibilities of metals relative to water, causing small local 
inhomogenities in the B0 magnetic field, and radiofrequency (RF) inhomogeneity (108).  
Rapid identification of these needles can be difficult particularly in areas of variable 
signal intensity.   For longer trajectories, identifying the angle and positioning of the 
needle is also challenging.   
Instantaneous knowledge of needle position angulation is critically important in 
cardiovascular applications.  Cardiovascular access typically also utilizes a needle with 
unobstructed lumen to allow bleed-back to confirm access and guidewire passage for 
sheath exchange.  For smooth advancement through the skin and soft-tissue during 
access, the needle construction must be robust.  To facilitate MRI-guided cardiovascular 
access, we developed an “active” MRI antenna-needle with an open-lumen, distinct tip 
appearance and indicators of depth and trajectory, for enhanced MRI visibility.  We then 
evaluated the device imaging appearance with regards to tip localization and shaft 
marker accuracy.   
 
3.2.1 Methods  
Active Needle Design and Construction  
The needle design aimed to incorporate active profiling to delineate the tip clearly 
while maintaining the desired mechanical properties (size, open-lumen, smooth 
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advancement) to allow the device to be used in vivo for cardiovascular applications.  An 
18-gauge MRI-compatible needle base, initially a commercially available 15cm Inconel
625 needle (EZ-EM, Lake Success, NY USA) and then a custom ground Nitinol needle, 
was modified to incorporate a loop antenna along its length.  In order to create a unique 
device “signature” appearance, areas of greatest signal intensity were produced with 
tighter copper wire (0.003” coated wire, California Fine Wire, Grover Beach, CA) coil 
windings around the insulated needle separated by unequal distances, starting just 
proximal to the tip (at the end of the bevel) and at 1, 3, 6, 10 and 15 cm away to provide 
distinguishable marker points.  Thermoplastic elastomer (Pebax) covering maintained a 
smooth transition on the outer surface from needle bevel to coil without a significant 
increase in outer diameter (<5Fr, 1.67mm) to allow smooth skin entry as seen in Figure 
3.2.1.     
 
 
Figure 3.2.1.  Active needle with close up of tip uncovered (A) and covered (B).
Needle with coaxial extension and circuit box seen in (C).   
 
To allow its free movement, the needle was connected initially to its remote tuning and 
matching circuitry via a 1-meter long coaxial cable extension.  The needle was 
impedance matched to 50 ohms at 63.67 MHz (Larmor frequency for 1.5T) for maximum 
power transfer, used in receive-only mode, and detuned during RF transmission with a 
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PIN diode and parallel resonant circuit to limit coupling with the high power RF transmit 
which may cause non-uniform excitation and potential device heating.   To eliminate the 
small coaxial cable and place the circuitry immediately at the needle to improve signal 
quality, localize detuning circuitry to the end of the coil, and enable the use of a larger 
shielded and trapped cable proximally, a version of the needle with circuitry embedded 
in a handle was also produced (Figure 3.2.2).   
 
 
Figure 3.2.2.  Active needle with circuitry in handle.
 
Imaging Evaluation  
All imaging and interventional procedures were performed in a short, wide bore 
1.5T MRI scanner (Espree, Siemens Medical Solutions, Erlangen, Germany) with 
36 

surface receive coils in addition to the independent active device channels.  The active 
needle and associated active devices (such as active guidewires) were connected to 
separate scanner receiver channels via a preamplifier box.     High resolution phantom 
images were acquired using 2D (TR/TE 3.92/1.96ms, flip angle 45º, field of view 
340x170mm, matrix 256x128, slice thickness 5mm) and 3D (FOV 340x340, matrix 
484x484, slab slice thickness 1mm, displayed as maximum intensity projection) 
balanced steady-state free precession (bSSFP) sequence.  Real-time bSSFP imaging 
(TR/TE 3.67/1.23ms, slice thickness 6mm, flip angle 45°, matrix 192x144) used a 
separate real-time reconstruction and display system (6) and was performed during 
phantom testing and in vivo animal experiments.  The active needle signal was 
displayed as a color overlay on the anatomical grayscale images in the real-time 
reconstruction system. 
 
In Vitro Needle Imaging Characterization  
In vitro testing was conducted in water phantoms under various conditions that 
may be experienced during in vivo use using the sequences described above.  To 
evaluate needle appearance changes during different orientations with respect to B0, the 
needle was fixed in place at the proximal end within a rectangular phantom that could be 
aligned parallel and perpendicular to B0.   Imaging was also performed with a stylet and 
guidewire occupying the device lumen test the possibility of signal cancellation or other 
unfavorable coupling.       
Signal-to-noise (SNR) maps to examine the device signal profile were generated 
using a single magnitude image of the device only channel.  The noise was calculated 
from a user-selected “noise-only” region outside the device and phantom and corrected 
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for the number of active channels (109,110).  Contrast to background imaging was 
compared for the active needle with and without the active channel on with the device 
oriented parallel and perpendicular to B0.  The minimum signal level was taken for the 
highest negative contrast value while the maximum signal level was used for positive 
contrast and compared to the average background signal.     
To characterize the accuracy of coil visualization in determining needle location, 
we recorded coil marker appearance along the device and measured tip and centerline 
deviations.  The device centerline and tip location were determined by fixing the needle 
in a custom plexiglass holder with small water channels providing MR visible distance 





Figure 3.2.3.  Device in holder with centerline and tip locations indicated by blue 
lines and centroids of coil signal in red.     
Marker locations were determined by the centroid of the marker points after threshold 
segmentation (Figure 3.2.4). The differences between the set tip position and visible tip 
position and deviation of signal intensity at the tip from the device centerline were 
calculated.  Signal widths also were measured for the marker points along the center of 
the marker point and characterized by the full width half maximum where the signal fell 
to 50% of the maximum level.
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Figure 3.2.4.  3D maximum intensity projection image of needle signal (A) with 
thresholding (B) and centroid calculation (C) of marker points.
 
3.2.2 Results 
Device Construction and Imaging Evaluation  
Needle construction and circuitry produced distinct points of increased signal 
intensity in phantom images corresponding to the prescribed spacing along the length of 
the needle.  A minimum spacing of 0.5 cm between tightly wound segments provided 
distinct markers that could be identified with the device parallel or perpendicular to B0.  
These points were visible despite changes in needle artifact size and appearance which 




Figure 3.2.5.  Active needle signal with parallel (A) and perpendicular (C) to B0.   
Device only SNR map shown in (B).      
 
The signal from the needle was also apparent when the needle was used with an 
accompanying MR-compatible stylet, passive nitinol guidewire, and active guidewire 





Figure 3.2.6.  Active needle signal seen in red with nitinol stylet (A), active 
guidewire (B – wire in green), and simulated lower signal tissue with needle in a 
hot dog and gain turned up (C).
 
 In the water phantom, the active signal provided 2 to 2.5-fold increase in signal 
compared to background.   With the needle parallel to B0 and the device channel off, the 
passive artifact is very narrow and only produced a small decrease in signal.  With the 
needle perpendicular to B0, the artifact is much broader and caused a decrease over 8-




Figure 3.2.7.  Signal intensity profiles (a.u.) for needle oriented parallel (left) and 
perpendicular (right) to B0 with and without device channel active.    
 
Table 3.2.1.  Relative signal and contrast values for active needle and 
corresponding passive needle artifact.
 Needle Parallel Needle Perpendicular 
Average Background Signal  649.6 677.6 
Minimum OFF  535 83 
Relative Negative Contrast  1.2 8.2 
Maximum ON  1614.0 1414.0 
Relative Positive Contrast  2.5 2.1 
 
 In quantitative measures of coil positioning and targeting accuracy, the active 
needle coil started 3.5 mm from the end of the needle bevel which resulted in a 
difference of 4.2 mm from the centroid of the most distal marker signal to the bevel end.  
The coils closely represented the true device centerline with centroids that deviated from 
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the actual needle central lumen by less than 0.5 mm (average for distal 3 points: 0.2 
mm, range: 0-0.38 mm).  The distance between the marker points measured by MRI 
were within 5% of the actual marker separation (average: 2.35%, range: 0.6-5%).   In 
considering the entire marker width, the signal width for half-maximum intensity with the 
needle parallel to B0 was 2.8mm compared to the actual device width of under 1.7mm 
(Figure 3.2.8).   
 
  
Figure 3.2.8.  Active needle Signal Profile with half-maximum (green lines) and 
needle appearance (gray) shown.
3.2.3 Discussion  
We have developed an active needle with distinct markers of needle position, 
trajectory and insertion depth.  The device construction also maintained a smooth profile 
for entry into the skin and central lumen available for blood return, pressure, aspiration, 
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and guidewire use.  The active needle allows rapid and clear device localization for 
percutaneous interventional MRI procedures with its distinct signal and image signature.  
The use of special MRI techniques like device-only projection for easy identification of 
device position and automated device finding and scan-plane prescription modes are 
also possible (6,111).   
Commercially available non-magnetic metal needles in materials such as 
Titanium (e.g.  In Vivo, others), Inconel 625 (e.g. EZ-EM), and other special alloys (e.g. 
Somatex) can appear in MRI larger than the actual device size and vary widely with 
exact needle composition, magnet field strength, orientation of the needle relative to B0, 
and imaging sequence (108,112,113).  As a result, the appearance of these passive 
needles may not accurately represent the actual needle location, making it unreliable or 
unsafe for targeting of small lesions.   Moreover, the needle susceptibility artifacts can 
be relatively large compared with vessel size, particularly when trajectories 
perpendicular to B0 are attempted (114).   Even with the larger needle artifacts the 
active signal helped more closely locate the actual device position and tip location.  We 
employed a nitinol needle body to try to further reduce the passive artifact appearance.  
Alternate non-metallic materials may be superior for visualization but at the expense of 
shaft-strength and sharp cutting edges in thin-walled needles.   
Larger carbon fiber needle cannulas (14G and 18G) previously had been 
commercially available having significantly smaller artifacts than titanium equivalents 
(115) but also used an inner metal stylet for entry.  A smaller carbon-fiber-reinforced 
plastic puncture needle was developed by Fraunhofer Institute for Production 
Technology (IPT) and is now available in Europe through RadiMed (Germany).  The MR 
visibility of these carbon alternatives, however, may actually be insufficient for our 
application without any modifications or additional metal stylet to make them more 
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apparent during imaging (116).    Other passive needle designs with specialized coatings 
also have been investigated to provide more precise tip location (117).   
Active visualization as displayed in this work could be incorporated into these 
non-metallic designs for greater visualization with little needle base artifact and further 
improve the safety profile by eliminating the metallic base if an appropriately size 
composite needle becomes available.  We demonstrated this by constructing a sample 
device using the small RadiMed needle base.  The needle is very difficult to see even in 
phantom imaging without any modification but the imaging markers were clearly visible 
with the active modification (Figure 3.2.9).            
 
 
Figure 3.2.9.  Active needle w/carbon fiber base construction (A).  MR imaging of 




While the needle handle was a little bulky in this demonstration to accommodate the 
currently used circuitry, the circuit components could be included in a much smaller 
needle hub.  Incorporating the circuitry in the base of the device and using the non-
metallic needle base could further improve the safe design of the device.   
Other investigators have applied a needle stylet designed with a tip tracking coil 
in a novel PEEK and ceramic tip construction which was used for targeting liver cysts 
and MR-guided cholecystostomy (118,119).   Tip tracking, however, requires 
independent acquisitions with tracking sequences where only the tip location and path is 
marked on prior or interspersed images.  In cases where the needle may curve or take 
trajectories through critical structures, identifying the entire location on simultaneously 
acquired imaging may be necessary to improve procedure safety.  Our approach to 
active imaging or profiling of a device provides the unique device signature on 
simultaneous real-time images.    Stylets are less useful in cardiovascular applications 
where back-bleeding, pressure-monitoring, and ready guidewire access through an open 
lumen are considered important.  The outer coating of the exterior coil was robust to skin 
entry and additional coatings could be used to reduce the friction and facilitate needle 
entry through the skin.   
  We assessed the active device profile as well as accuracy of the signal location 
to guide the requisite intervention.  The marker signal closely reflected the actual device 
location with some discrepancy between the tip location and actual bevel, restricted by 
physical limits on distal placement of hand-wound coils.  The signal width was also 
slightly greater than the actual device size.  Decreasing the wire size could reduce this 
but at the expense of overall signal loss, and of greater manufacturing challenges of the 
more fragile small diameter wire.  A grooved needle base may also be possible to 
embed the coils, reducing both physical and signal profiles.  This also could be 
47 

addressed with image post-processing and device channel display properties.   For 
example, sharper device delineation is provided in the real-time reconstruction and 
display system by squaring of the device channel signal (6).   
In summary, we have presented a robust active needle design that provides clear 
tip and shaft visualization, and versatility for in vivo applications.   Extensive 
demonstration and discussion of the in vivo utility of the active needle is presented in 
Chapter 5 on MRI-Guided Cardiovascular Access.  Standardization of this approach to 
device signal evaluation will be helpful in characterization and assessment of MRI 
performance of a range of actively visualized devices including guidewires and 
catheters.    
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3.3 Active Cable 
Non-surgical catheter-based device approaches are increasingly applied to treat 
a range of structural heart diseases.   Such procedures could benefit from the anatomic 
context and dynamic information provided by MRI but the commercial devices typically 
used are often incompatible in the MR environment and small implants or target 
structures can be difficult to visualize.  For atrial and ventricular septal occluder device 
delivery, the main component of these devices consists of a nitinol mesh where the disks 
appear as small signal voids on MR imaging without significant artifacts.  Release of 
these nitinol occluder devices, which are attached by a screw to their delivery cable, 
requires a defined torque maneuver of the delivery cable.  The delivery system which 
utilizes stainless steel mating screws produces sizable artifacts which completely 
obscure the device in imaging (Figure 3.3.1).   
 
Figure 3.3.1.  Commercial VSD occluder and delivery cable with stainless steel 
mating screws.
 
To improve MRI visibility during device deployment, the visibility of the disks is 
necessary while minimizing the image artifacts.  This would enable the operator to better 
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visualize device deployment and positioning, taking advantage of MRI soft-tissue 
depiction to enhance procedural conduct and success.  In addition, the delivery system 
must maintain its ability to reliably advance the disks and release the device upon 
deployment.  We hypothesized that visualization of the occluder device deployment 
under MRI could be improved through the use of an active delivery cable where the 
implant, when attached, also becomes part of the active device.  We tested this 
hypothesis in phantom testing and in a novel series of minimally invasive applications 
being developed in the laboratory, in which we treat structural heart disease directly 
through the walls of the chest and the heart in a beating heart without surgical incisions 
or exposure.   
 
3.3.1 Methods 
Active Cable Design and Construction  
To improve the visibility of passive implant deployment, an active delivery cable 
was created comprising a loopless antenna.  For device advancement and torquability, a 
nitinol inner conductor was used.  The nitinol construction produces minimal MR artifacts 
and provides a superelastic core that is less prone to kinking while still providing 
sufficient pushability and torquability of the device.  It was connected via laser welding to 
the mating screw for attachment of atrial and ventricular septal defect closure devices 
and vascular plugs and then insulated (Figure 3.3.2).  A nitinol hypotube served as the 





Figure 3.3.2.  Inner rod of loopless construction with attached microscrew and 
occluder device.
 
A titanium mating screw was used on the cable to avoid the significant artifacts 
caused by stainless steel elements of the commercial delivery construction.      Figure 
3.3.3 shows cables with titanium and stainless steels screws and the sizable reduction in 
artifact.   
 
 
Figure 3.3.3. MR imaging artifacts of titanium replacement (left - arrow) and 





The cable performance was evaluated using off-the-shelf VSD occluder devices which 
retained the stainless steel microscrew and devices that were specially constructed with 
titanium replacements to further reduce artifacts (Figure 3.3.3).  With the artifact 
removed, the borders of the unconstrained nitinol devices are recognized from their 
passive characteristics in a phantom.   
Several additional design modifications were employed to ensure the mechanical 
handling and utility of the device.  The nitinol core and hypotube were adjusted in both 
diameter to affect stiffness and torquability and length depending on the device delivery 
and target anatomy.  For example, in transthoracic procedures, a shorter cable was 
developed and tuned accordingly with a handle designed to secure the circuitry and 
allow torquability with a rotating adaptor at the proximal connection (Figure 3.3.4).  This 
enabled the device to be used by a single operator in closure of cardiac defects and 
helped address the additional connection requirements necessitated by active device 
use and protect the device connection during normal use and rotation. 
 
 




Electrical characteristics and imaging evaluation 
 Reflection (S11) measurements were made with the cable alone and with the 
device attached.  The cable was tuned and matched with the device attached to 
maximize signal.  The signal profile was evaluated in the different deployment states: no 
device, device fully sheathed, 1-disk released, and 2-disks released.     
 
In vivo demonstration  
In addition to signal evaluation in saline phantoms, the active cable performance 
was evaluated during in vivo use for MRI-guided transthoracic VSD closure and left 
ventricular access closure and ASD occluder delivery in swine.  Animal experiment 
protocols were approved by the institutional animal care and use committee, according 
to contemporary NIH guidelines.
 
3.3.2 Results 
Electrical characteristics and In vitro imaging  
Attaching the device to the cable changed the electrical characteristics and the 
antenna could be tuned and matched (closest to 50 ohms resistance  - real component 
of impedance - with no reactance – imaginary component of impedance - at 64 MHz) 






Table 3.3.1.  Differences in signal intensity and impedance of cable with and 
without device attached 
 
In extending the whip of the loopless antenna by attaching the device and tuning the 
cable accordingly, signal was also present all the way up to the device which increased 
the contrast of the passive implant artifact during deployment. This is seen in Figure 
3.3.5 which shows the various deployment states and one-disk deployment can be 
clearly seen with the occluder devices that still possessed the stainless steel screw and 
those with the titanium replacements.   
 
 w/o Device w/8mm Device 
Signal Profiles 
Impedance Measurements 
(Ohms) Resistance Reactance Resistance Reactance 
Air 5 15 5 16 
Tip submerged in saline 13 17.5 15 12 
Junction submerged 12.5 25 20 30 




Figure 3.3.5.  Device deployment states and corresponding phantom images with 
active delivery cable and unmodified commercial device and device with titanium 
screw.  Arrow indicates distal disk with arrowhead pointing at the proximal disk.   
 
In vivo demonstration  
The active cable provided the operator necessary visualization for confident VSD 
and ASD device deployment under MRI guidance.  The cables were able to reach their 
intended target, advance the disks appropriately from the delivery sheath, and release 
the device with reasonable rotation applied.  Figure 3.3.6 shows the short cable in use 
for transthoracic VSD closure (120) where the pediatric cardiologist could clearly 
visualize LV disk signal void in both views with passive disk appearance contrasted 





Figure 3.3.6.  Left ventricle disk (arrow) release evident during transthoracic VSD 
device deployment.
 
Figure 3.3.7 shows an example of where the operator felt resistance when pulling 
the LV disk back towards the septum but the imaging with active cable signal showed 
that the device was caught in subvalvular structures and not opposed to the septum so it 
was resheathed and properly redeployed.  This was not as readily apparent with the 





Figure 3.3.7.  Proximal disk (arrow) caught on subvalvular structures seen in 
angled coronal view in (A) and clearly not opposed to interventricular septum in 
short axis (B).  This is less readily apparent without the active device signal (C). 
 
During experiments to evaluate the feasibility of VSD occluder device 
deployment to close percutaneous left ventricular apical large sheath access (121), the 
cable signal helped the cardiologist confirm that the proximal disk was opposed to the 
endocardial surface and the epicardial disk was positioned within the pericardial space 
before the device was released (Figure 3.3.8).  This positioning is critical to ensure that 
the device is securely in place and pericardial entrapment doesn’t cause tension on the 





Figure 3.3.8.  Endocardial (arrow) and epicardial (arrowhead) disk deployment 
clearly seen in LV apical access closure with active cable and modified device.   
 
A longer, more flexible active delivery cable also enabled ASD closure with a 
commercial device from a transfemoral approach which is shown in Figure 3.3.9.  The 
commercial ASD occluder positioning and disk deployment was enhanced with the 
active cable signal.  Similar longer, more flexible cable designs could also enable 
transfemoral VSD occlusion and vascular plug delivery.   
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Figure 3.3.9.  Device in place in atrial septum prior to release from the cable.   
 
3.3.3 Discussion  
Operators had much greater confidence in device position, state, delivery, and 
deployment compared to previous in vivo trials without the active cable.   Proper 
deployment and positioning of the first disk is critical and the increased visibility of this 
disk allowed the operator to ensure it was properly opposed to the intended structure 
and take full advantage of the soft-tissue imaging afforded by MRI.  
Incorporating the device as part of the loopless antenna and appropriate tuning 
helped provide signal all the way to the distal disk whereas loopless antennas normally 
have signal drop-off towards the tip which was seen when the device was not 
connected.  With the motion and varying signal in the heart, this was essential for clear 
determination of distal disk release and placement.   
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Compared to the commercial delivery cable, our cable typically had similar 
stiffness at the distal end where the nitinol rod extended as the whip and increased 
stiffness proximally where the additional nitinol hypotube served as the outer conductor 
for the loopless antenna construction.  This did not seem to impact performance and in 
some instances made the devices easier to deploy by providing increased proximal 
pushability.    Release of the device with the modified delivery system with handle and 
rotatable connector was not as constrained by attachment to the scanner necessary for 
active   
While the titanium parts replacement largely eliminated the artifacts associated 
with the device delivery system, they do present some additional challenges compared 
to stainless steel.  Titanium is much harder to machine than stainless steel, particularly 
with small components such as these screws, and companies with these capabilities are 
limited.  The less common use of the material compared to stainless steel and more 
complex processing make this option more expensive.  Furthermore, in these threaded 
parts, there is concern over increased risk of defective parts or stripping the screw 
threads since the hardness and stiffness may be less and the weight-to-strength benefit 
of titanium cannot be appreciated in such small parts.  However, this risk still exists with 
stainless steel microscrews given the small size of the thread features and caution must 
be taken during device use to mitigate this risk.  For general application of these 
devices, the benefits of less impacted future MRI imaging studies following implantation 
and the material and manufacturing limitations would have to be considered,  
We also pursued imaging techniques to reduce the impact of the device artifact 
to enable use of commercial implants if device modification is undesirable.  We tried to 
improve the implant appearance in those that retained the original screw by testing 
sequences which are less susceptible to artifacts by using short echo times and 
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refocusing pulses (spin echo) as seen in Figure 3.3.10.  Distal disk release appearance 
is highly dependent on the size of device and corresponding length of elongation in the 
sheath which provides a natural separation between the screw causing the artifact and 
the released disk.   The fully deployed device appearance was improved with the turbo 
spin echo (TSE) imaging, but artifact impact was similar or worse using gradient recalled 
echo (GRE) real-time compared with SSFP techniques.  Other ultra-short TE imaging or 
specialized approaches to reduce metal artifacts (122) could also be used but may not 
be suitable for real-time guidance for device deployment.   
 
 
 Figure 3.3.10.  Imaging deployment of unmodified (stainless-steel-containing) 
commercial devices with different sequence parameters.  Distal disk marked by 
arrow and proximal disk with arrowhead.   
 In summary, the custom active delivery cable, with or without substitution of steel 
elements of the nitinol occluder device, allowed and enhanced performance of MRI-
guided device positioning in phantom and in vivo.  This enabled a completely new family 
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of pre-clinical interventional cardiovascular procedures, namely direct transthoracic 
cardiac access and repair of heart defects.  
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3.4 Active Configurable Laser Delivery System 
A transjugular intrahepatic portosystemic shunt (TIPS) procedure creates a direct 
connection between the hepatic and portal veins to reduce portal hypertension and 
associated conditions like life-threatening variceal hemorrhage.  Early use of TIPS was 
shown to reduce morbidity and mortality compared with rescue procedures in patients 
with cirrhosis and variceal bleeding (123).  TIPS creation is performed clinically under X-
ray guidance.  Connecting the hepatic and portal veins can take more than 50 needle 
passes, because the target portal vein is difficult to visualize under angiography.  MRI 
guidance for TIPS can provide clear visualization of hepatic and portal vein structures 
without exogenous contrast which may help reduce procedure length, x-ray exposure 
and risk of significant complications especially extracapsular, subcapsular, and biliary 
bleeding (Figure 3.4.1).   
 
Figure 3.4.1.  MRI imaging of hepatic and portal veins.  Vessels are apparent 




This procedure has been demonstrated in patients using hybrid MR/X-ray 
systems but device visualization under MRI was limited, and much of the procedure was 
performed using the in-magnet X-ray system (26).   Clinically, TIPS is typically 
performed with needle catheters or stylets.  Needle attempts may be difficult in patients 
because of rigid fibrotic livers of cirrhosis.  Applying a vessel crossing system with an 
energy source could provide a more controlled and effective passage while minimizing 
regional damage and hazard.  
An energy source such an excimer laser could be used to accomplish these 
traversals, but this method requires additional positioning and support for advancement 
in order to achieve the desired trajectory.  Preliminary experiments in excised liver tissue 
indicated that the mechanical properties of the active laser alone were not sufficient to 
perform the TIPS procedure without an additional delivery system.    The active laser 
lacks the stiffness to maintain a straight trajectory through the liver parenchyma when 
advanced by the operator. 
 The anatomical relationship between the hepatic vein and the portal vein 
requires the ability to direct and steer the active laser into the proper position in the 
vasculature and then through the liver parenchyma.  The system must first access the 
hepatic vein branch from the IVC with a rightward deviation and then reorientated almost 
completely anteriorly to pass to the desired portal vein branch.   In initial testing, long 
active needle designs with polymer shafts were difficult to position and did not have the 
necessary shaft stiffness for advancement.  Preliminary testing of the laser alone for liver 
passage showed that it could not be positioned and advanced without sufficient back 
support to keep it from buckling or veering off-target.  Therefore, a delivery system was 
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developed to provide back-up support to the laser as well as the necessary curvature 
and visualization to direct the laser into the hepatic vein and towards the portal vein.  We 
then tested the feasibility of this method to perform the TIPS procedure under real-time 
MRI guidance using actively visualized excimer laser and delivery system.   
  
3.4.1 Methods 
The active delivery system design incorporated two insulated concentric nitinol 
hypotubes, each with a unique curvature which also formed the inner and outer 
conductors of a loopless antenna to provide both signal to indicate the laser positioning 
curvature and highly configurable positioning.  The curvature in the nitinol tubing was 
instilled under mechanical stress during annealing. Curvatures were selected to achieve 
the necessary curve reach and advancement for the target anatomy while also 
permitting ready resheathing of the inner tube.  Hypotube size was selected to allow 
shape processing and adequate mechanical handling.  When increased curvature and 
more torquability was required, the wall thickness of the inner tube was increased to 
prevent kinking with the greater curvature and also provided more shaft support and 
torque responsiveness during rotation.  This was balanced with not selecting too great of 
a wall thickness where the inner tube could not be easily resheathed by the outer tube 
due to loss of flexibility.   The inner hypotube could be advanced and withdrawn as well 
as rotated within the outer hypotube as necessary to modify the curvature of the inner 





Figure 3.4.2.  Nitinol hypotube constrained in the desired positioning before 
annealing (left column) and then the shape retention seen after (right).  The 
hypotubes could then be placed inside one another and variably deployed.
 
After annealing, the inner (0.062” ID, 0.072” OD) and outer (0.104” ID, 0.112”OD) 
nitinol hypotubes were insulated with PTFE liners and thermoplastic (PEBAX) exterior 
insulation to form the components of the loopless antenna and enable smooth 
movement of the two tubes relative to each other.  Connection at the proximal end used 
a flexible, adjustable connector to tolerate the variable positioning of the two parts.  Each 
tube also had its own adapter to allow independent flushing of the two parts of the 
system.  The inner lumen of the delivery system was 0.057” and the outer diameter of 
the entire system was 0.120” (<10 Fr).  An MRI-compatible excimer laser catheter was 
modified to include a single loop channel at the distal tip enabling active visualization 
under real-time MRI (Spectranetics, Colorado Springs, CO).    The outer diameter of the 
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excimer laser was 0.045” (4 French compatible).  The entire system with the variable 
deployment states and laser exiting from the tip is shown in Figure 3.4.3.   
 
Figure 3.4.3.  Complete system with flexible connector and variable states with 
laser deployed.
 
The excimer laser and delivery system were each connected to scanner receive 
channels via tuning, matching and decoupling circuitry and a multi-channel preamplifier 
box.  Device signal with the laser was first evaluated in saline phantoms and in an ex
vivo liver.  Mechanical device performance was tested for vessel traversal in ex vivo liver 
tissue.  An in vivo feasibility study of laser-mediated hepatic to portal puncture in swine 
under real-time MRI guidance demonstrated both device visualization and functional 





The configurable system enabled the operator to vary the amount of curvature as 
well as easily alter shape by rotating the inner tube relative to the outer one to produce C 
and S-shaped configurations (Figure 3.4.4).  The system could be delivered to the liver 
with the inner tube retracted and then deployed and rotated to reach the target site.   
 
Figure 3.4.4.  Rotation of the inner hypotube allows C and S-shaped curvatures.   
  
In phantom imaging, the device curvature was clearly visible with an increase in 
signal when the inner sheath was extended and the loop coil on the laser providing the 




Figure 3.4.5.  Phantom and ex vivo liver imaging of the active delivery system and 
laser.
 
During the in vivo feasibility study in swine, the delivery system was able to direct 
and provide back-up support to the laser which successfully burned through the hepatic 
vein wall, the liver parenchyma and into the portal vein (Figure 3.4.6).  The system was 
delivered with the inner tube sheathed until the liver was reached and the necessary 
curvature released by advancing the inner tube.  To alter the direction of the curvature, 
the inner tube was easily rotated and positioned appropriately.  First, the system was 
angled to the right and positioned into the right hepatic vein branch and then the inner 
tube rotated anteriorly to aim towards the target portal vein branch.  The configurable 
system and advanced imaging guidance enabled a novice operator to successfully 
perform this extremely complex interventional procedure.   The system was tested with 




Figure 3.4.6.  Accessing the portal vein in vivo.  Laser enter portal vein (A) with 
projection mode image of delivery system to indicate the orientation (B).
 
3.4.3 Discussion  
The excimer laser and delivery system facilitated targeted passage from the 
hepatic to portal veins with minimal resistance in naïve swine liver.  Additional testing in 
fibrotic livers is necessary.  The ability to rotate the inner hypotube relative to the outer 
hypotube proved invaluable during the in vivo demonstration because it enabled quick 
alteration of the device position to achieve the desired angulation and trajectory.     
While the delivery system loopless design had limited signal at the distal tip as is 
typical of loopless antennas, the loop coil at the distal end of laser provided 
complimentary signal for complete device visualization.  Signal along the device shaft 
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was appreciable when the inner tube was retracted but increased as expected with 
advancement of the inner component that effectively created the whip of the loopless 
antenna.  For procedures that may traverse low signal areas between vascular targets 
such as in the mediastinum, internal signal sources might be necessary for proper laser 
tip position and angulation.   
 In summary, we developed a configurable, loopless active MRI guiding catheter 
to work in tandem with an active loop-coil-tipped excimer laser catheter.  We used these 
together to conduct a TIPS procedure in healthy swine.  Of note, the MRI vessel 
guidance and enhanced conspicuity and satisfactory mechanical performance of these 
image-guided catheter devices allowed even a novice non-physician operator 
successfully to conduct a highly specialized vascular interventional procedure.  This 
system provides a visible, controllable and adaptable approach to vessel and tissue 
passage that could be used for other novel MRI-guided examples of extra-anatomic 
bypass such as a Blalock-Taussig aorto-pulmonary shunt.  
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3.5 Chapter Summary and Contributions 
In this chapter, we have presented distinct devices to enable three different types 
of MRI-guided cardiovascular interventional procedures.  Each device design 
incorporated considerations for device utility and MRI visibility.  Each were evaluated in 
phantom testing and then during in vivo procedure feasibility animal studies.  The active 
needle provided distinct tip and shaft visualization within a robust construction that 
permitted the studies described in Chapter 5.  The active delivery cable incorporated the 
device into the active antenna design and permitted cardiac implant delivery with greater 
operator confidence in device deployment and positioning.  The active laser delivery 
system provided the necessary support and positioning for the active laser catheter to 
permit initial feasibility trials of TIPS, an example of extra-anatomic bypass facilitated by 
MRI guidance.  A thorough evaluation of the device signal performance also was 






INTERVENTIONAL MRI SAFETY 
 
4.1 Introduction  
A comprehensive approach to evaluating device heating is necessary to 
determine the parameters under which these devices with conductive components can 
be used safely in the MR environment and without risk to the patient or operator.  The 
numerous variables that can influence heating in the MR environment and the 
complexity of the devices make it difficult to employ electromagnetic (EM) simulations 
and necessitate extensive experimental testing for validation.  Most of the observations 
on device heating in MR examined bare or simple insulated wires and/or limited insertion 
lengths in disparate phantoms filled with different media and show differing results (124).   
Current standards focus on conservative device positioning in extreme horizontal 
off-sets with devices aligned parallel in high local E-field regions that may never be 
encountered during constrained clinical procedures (125).  In endovascular cardiac 
procedures, devices are limited to the vasculature in passing from peripheral vascular 
entry (access) points and thereafter to the central vessels and the heart.  Trajectories 
from femoral access follow the centrally located, in both right-left and anterior-posterior 
aspects, aortic and caval vessels.  Limited information is available on actual device 
heating in larger animal models which would more closely represent the clinical use 
scenario.  Table 4.1.1 outlines the advantages of the different methods to investigate 
potential heating as well as their shortcomings. 
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Identify key parameters for device 
design 
Inform phantom testing process for 
areas of maximum heating 
Human simulation possible in 
multiple configurations  
Difficult to simulate complex device 
constructions with many 
simplifications and assumptions 
necessary  
SAR distribution does not 
necessarily = heating 
Device and human simulations 
must be validated 
Computation time and expense in 
model development  
Phantom
testing
Investigate important variables 
identified and relative influences on 
heating and signal  
Test device prototypes for heating 
profiles  
Phantom geometry doesn’t 
represent animal or human (shape, 
assymetry, E-field distribution) 
Typically test “worst-case” 
positioning not reflective of actual 
use 
Significant externalized wire portion 
can impact results 
Animal
testing
Temperature measurements during 
simulated normal use 
Observe influence of perfusion with 
in vivo and in situ measurements 
Animal shape does not represent 
human anatomy and may impact 
corresponding E-field distribution 
and conditions of use  
Procedures are dynamic and 





Continual temperature monitoring 
and potential scanner feedback 
during use to ensure patient safety 
and determine appropriate 
operating conditions  
Need physiological data to evaluate 
human simulations  
May not experience range of 




In this work, we started with testing in gel phantoms to characterize the heating 
potential of our active interventional devices and determine the critical testing 
parameters as well as improved evaluation methods.  Animal studies provided an in vivo 
comparison of device heating potential during typical use and the additional reduction of 
heating from blood flow and thermal regulation.  Finally, we implemented an approach 
for device monitoring and dynamic scanner feedback control to further assure active 




4.2 Components of Active Device Safety 
In this section, we explore the heating characteristics of our devices in phantom 
studies with initial in vivo correlates.  Eddy currents induced in the phantom lead to high 
E-field and local SAR distributions which have been demonstrated in EM calculation and 
simulations (126).  Horizontal off-set and depth positioning first were tested to correlate 
the level of device heating observed in these high E-field regions and contrasted with 
more realistic device positioning.   Critical insertion lengths, or resonant lengths, may not 
occur at half-wavelengths near 25cm for dielectric of the phantom with each device 
construction.  The devices contain varied electric conductors and coils and are 
differentially insulated along the wire length which can alter the effective dielectric and 
electrical length of the wire.    The device and placement variability may also impact the 
points that may experience the most heating.  We also investigated potential approaches 
to limit RF interactions such as RF shielding to see if it could limit the interactions with 
the exposed wire and a floating trap to try to suppress unwanted shield currents on the 
external wire and examine their effects on heating.   
 
4.2.1 Methods 
Phantom Design  
Phantom testing was conducted using a 72 cm x 42 cm x 19 cm rectangular 
acrylic phantom (Acrylic Custom Works, Rockville, MD) filled to 9cm with a polyacrylic 
acid (PAA) gel formulation (30L distilled water, 1.32 g/L NaCl (Sigma-Aldrich, St. Louis, 
MO), 10 g/L PAA (Sigma-Aldrich 436364) in accordance with ASTM standard 2182-02 
and subsequent 09 revisions (125) .   This provides a gel with similar conductivity and 
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dielectric properties as tissue with the gel limiting convective heat transfer.  Access 
points were drilled in the end wall at 0, 2.5, 7.6, and 12.7 cm offsets.  A polypropylene 
pegboard with 2.5 cm grid spacing (Pegboard with 9/32” holes, McMaster-Carr, 
Robbinsville, NJ) was secured to the bottom of the phantom.  Acrylic rods (5/16” 
extruded acrylic rod, McMaster-Carr, Robbinsville, NJ) were cut to varying heights (2, 4, 
6, 8 cm) and machined to fit the peg board and with a groove at the top.  Flat nylon 
washers (#12 screw size, McMaster-Carr, Robbinsville, NJ) were affixed into the grove 
of the top of the rod with Epoxy and used to keep the device on the support pegs.  For a 
given trajectory, the pegs were placed at least every 10 cm but not at a point of 
temperature measurement.  A consistent patient registration was used for the scanning 
with the phantom including an entered weight of 200 pounds and minimum age of 18 
years for no restrictions on scanner power output.   
  Using this pegboard and rod system to secure the device location in the 
phantom, we investigated different device positioning by varying horizontal offsets 
(distance from horizontal isocenter), depths (from bottom of the phantom) and insertion 
lengths (length of guidewire in phantom from entry point to tip).   The center of the 
phantom was placed in the isocenter of the magnet with shifts of the phantom along the 
z-axis of the magnet also tested to examine the effect of varying isocenter.   The 
phantom also incorporated modifications including a hollow acrylic v-shape (Acrylic 
Custom Works, Rockville, MD) to simulate the groin region and femoral vessel phantom 
(Lake Forest Anatomicals, Lake Forest, IL).  The phantom set-up is shown in Figure 




Figure 4.2.1.  Heating phantom including a V-shape with wire secured with 
pegboard and rods.
 
Temperature Measurement  
Temperature measurements were performed using fiber-optic temperature 
measurement systems with either white-light polarization interferometry sensors (FOT-M 
temperature sensor, FISO, Quebec, CN) or semi-conductor band gap technology with a 
Gallium arsenide crystal (OTG-M170, OpSens, Quebec, CN).  Significantly smaller 
sensors currently are available with the semiconductor-based sensor as small as 62 
micron for the sensor with an 80 micron signal transmission fiber.  The larger 
temperature sensors were initially attached to the exterior of the guidewire at key 
transition points using small rubber O-rings (McMaster-Carr, Robbinsville, NJ) to keep 
the sensors close to the device without the use of an adhesive which could damage the 
device and/or sensor.  Smaller sensors were attached with thin-walled heat shrink 
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(Advanced Polymer, Salem, NH) for testing in the anatomic configurations and initial 
testing in vivo in swine.  Corresponding signal conditioners were connected to a 
personal computer running the appropriate acquisition software.  Post-processing of the 
temperature data was performed to determine baseline temperatures, increase from 
baseline, and rates of increase.  Results are normalized to the maximum heating 
observed in a trial to observe trends and reduce variability between absolute guidewire 
measurements which may have been dependent on the particular guidewire build and 
small variations in temperature sensor placement.    
 
Device Testing Conditions 
The devices tested for this analysis were mainly one or two channel 0.035” active 
guidewires with a tip coil and loopless antenna construction in the shaft (127).  Prior to 
testing, the guidewires were marked with a silver permanent marker to indicate the 
varying insertion lengths to be tested and improve device placement reliability.  The 
phantom was similarly marked to indicate tip position for a given insertion length.  Active 
devices were connected to the scanner via their tune, match and decoupling circuitry, a 
coaxial cable, and then preamplifier box.  Non-magnetic coaxial cables were tested in 
varying lengths.  Additionally, a coaxial cable was constructed with a quarter-wave 
coaxial choke using a triaxial cable and shorting the two shields a quarter-wave from the 
open end to form a high impedance block there to shield currents on the cable.    
Alterations to the externalized guidewire (portion not submerged in the phantom) 
were also tested for their impact on device heating on a 1m long guidewire.    A PVC 
cylinder was covered with RF shielding material (Magmedix, Fitchburg, MA) and placed 
over the external portion of the guidewire.  A floating trap which could be slid over the 
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guidewire was constructed from concentric copper tubes (McMaster-Carr, Robbinsville, 
NJ) with one end shorted with a conductive flat washer (McMaster-Carr, Robbinsville, 
NJ) and the other end tuned to 64 MHz with non-magnetic capacitors (ATC, Huntington 
Station, NY).      
 
SAR Measurements and Applied Power Comparison  
Given the reported variability of SAR measurements for various scanners (128), 
whole-body SAR calorimetry measurements were performed to confirm the SAR values 
reported by the scanner in accordance with NEMA standard test protocols (129).  A 
similarly sized phantom as that used for the device testing was insulated with 2.5 cm 
thick polyurethane foam insulation (McMaster-Carr, Robbinsville, NJ).  Only NaCl was 
added to achieve the desired conductivity without gel since this test examines the 
temperature rise of the entire volume.  The sequence was run for 2 hours to generate 
sufficient heating for measurement.   SAR was calculated using a specific heat capacity 
(Cp) of 4186 J/kg-C for the saline fill and Equation 4.2.1.   




Scanner reported SAR, B1rms and power applied during scanning of a phantom, large 
swine and normal human subjects were compared to identify appropriate testing 
conditions for phantom studies relative to values for animal and human imaging.  Animal 
experiment protocols were approved by the institutional animal care and use committee, 
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according to contemporary NIH guidelines.  Human scanning was performed in 
accordance with IRB approved protocol. 
 
Realistic Positioning and Initial In vivo Testing  
Since the edge of the phantom represents a high E-field environment that may 
not be experienced in vivo for the intended application of our devices, we tried to identify 
the level of heating expected in vivo and realistic positioning in the phantom.  Initial in
vivo measurements in swine were made with the temperature sensors attached to the 
guidewire (2 at the tip and 1 at the junction) with heat shrink as described earlier (Figure 
4.2.2).   
 
 
Figure 4.2.2.  Fiber-optic temperature sensors attached to the tip of the 0.035” 
guidewire.
 
Similar positioning was also modeled in the phantom and compared with extreme 
horizontal off-set for the same guidewire.  The wires were positioned, baseline 
temperature acquired, and scanned for the same period of time in the different 





Horizontal Offset and Depth  
 Significant asymmetry was observed in device heating on either side of the 
phantom which correlates with the asymmetric phantom current distribution.  On what 
would be the patient right side of the phantom in a head-first, supine positioning, higher 
heating was seen with device placement closer to the bottom of the phantom compared 
to shallower positioning.  Similar offsets on the left-side of the phantom produced 
considerably higher heating than seen on the right with the peak seen instead at the 
shallower depths.     Figure 4.2.3 shows different in heating for wire positioning on the 
right and left sides of the phantom with varying wire depth.   
 
 




Insertion Length and Points of Device Heating 
Peak heating at the tip for the guidewires tested was seen at insertion lengths 
between 30 and 40cm with the wire aligned along the z-axis of the bore.  These insertion 
length trends were observed both at extreme horizontal offsets in the phantom as well as 
along the midline of the phantom with measurements made with increased power 
deposition to get achieve appreciable heating.  The level of heating was highly 
dependent on the exact wire placement and multiple measurements were made trying to 
place the wire at the same insertion length and maximum value measured could vary up 
to about 20%.  Other regions of the guidewire such as the hypotube junction did not 
necessarily have maximum heating at the same insertion lengths as the tip which is 
seen in Figure 4.2.4.        
 
 





Moving the phantom along the z-axis of the scanner bore by adjusting the table 
position so the center of the phantom was changed relative to the isocenter of the 
magnet also influenced the level of heating observed.  The isocenter position that 
produced the maximum heating was related to the given insertion length (Figure 4.2.5).     
 
   
Figure 4.2.5.  Impact of isocenter positioning for different insertion lengths.
 
Coaxial Extension Cable  
Coaxial cable initially was used to connect the device circuit box to the 
preamplifier box.  Varying the length and properties of this cable altered the level of tip 
heating observed.  One length of wire was not beneficial for all guidewires and 
positioning nor did heating reduce as wires got progressively longer or shorter.  There 
appeared to be particular lengths which may produce some reduction in heating but the 
response was unpredictable.  The choked triaxial cable produced slightly lower heating 
than an equivalent length coaxial cable when used in the orientation with the trap distal.  
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Figure 4.2.6 shows the heating curves for a guidewire unmoved during acquisitions with 
only changes in the coaxial cable length.    
 
 
Figure 4.2.6.  Relative tip heating for varying lengths of coxial extension cable.   
 
Externalized Guidewire  
The RF shield and floating trap did not have an appreciable effect on wire 
heating for the 1-m long wire.  When the externalized wire was brought in contact with 
the edge of the bore, increases in heating were intermittently observed but difficult to 







Scanner reported SAR values correlated with calorimetry measured values once the coil 
files for the preamplifier box were appropriately corrected.  In power comparisons we 
performed, B1rms estimations reported by the scanner were similar for the same 
sequence and duration in the phantom and human but WB-SAR and power deposited 
values differed (Table 4.2.1).  The average power deposited (Watts) was approximately 
two-thirds for the phantom than the values observed in animal and human subjects 
scanned for comparison.   The B1rms values were highest for the sample swine 
experiments.   
 
Table 4.2.1.  Scanner Reported Power Indicators for Phantom and Human subject.   
RT SSFP 
sequence  
45 FA (3 
slices) 
Whole Body 




Measured by Scanner 
(W)  
Human Subject 
(200 lb)  
Chest landmark  1.19  7.47  158.27  
Phantom  
Center 




1.09 8.32 148.17 
 
Anatomic Positioning 
Anatomic positioning and initial in vivo testing in similar configurations 
demonstrated the dramatic difference in level of heating observed under theses 
circumstances compared to the “worst-case” phantom positioning.  The wire was placed 
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across the iliac bifurcation representing a very superficial positioning and half-loop 
configuration which could represent one of the more clinically relevant “worst-case” 
positioning.  Observed heating was less than a 1/20th of the maximum at the extreme 
off-set.  Figure 4.2.7 shows images or photos the various positioning compared and the 
relative levels of device heating.    A considerable difference (~30%) in the two 
temperature sensors was also observed particularly for the higher heating levels.   
 
 
Figure 4.2.7.  Realistic positioning in phantom and initial in vivo animal trials 
compared with phantom edge placement.
 
4.2.3 Discussion  
 Phantom testing demonstrated the importance of device positioning (horizontal 
offset and depth) on the level of heating observed and correlation to the predicted E-field 





with maximum heating seen at varying insertion lengths which further reflects the 
changing current distribution phantom as its position in the phantom is moved.  The 
trends we observed in device heating correlate with the simulated E-field distribution and 
the experimentally measured E-field distributions and corresponding implant heating 
recently described by Nordbeck and colleagues (130,131) for varying offsets and 
insertion lengths.  Practical device testing and considerations with passive devices have 
also presented similar trends (132,133).   
Critical insertion lengths not only were located in these high E-field region areas 
of the phantom but held for centrally placed wires as well.  While the half-wave length in 
water with a dielectric of 80 like our phantom is approximately 26cm, the devices are 
comprised of different conductors and have thin layers (0.002-0.004”) of exterior 
insulation with much lower dielectric constants which slightly increases the resonant 
length (Equation 4.2.2).  Blood has a dielectric constant of 86 which is closely 
represented by the phantom formulation and a similar peak may be expected in vivo for 
certain insertion lengths.        





  Coaxial cable may have an appreciable change on guidewire heating in addition 
to signal loss and should be considered or eliminated if possible.  This effect can be 
further influenced by the device insertion length and the circuitry used which may be 
altering the total electrical length of the wire.  Certain lengths may cause the effective 
wire length to reach unfavorable multiples of a half-wavelength with increased heating.  
The cables themselves can act as linear or looped antennas depending on orientation 
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and interact with the B and E-fields that may extend beyond the confines of the transmit 
coil, particularly in short-bore magnets.  At a minimum, the cables should contain cable 
traps or chokes like receive coil connectors to limit induced currents and having them act 
as antennas as well.  As an alternative to the use of coaxial cables, we also developed 
an adapter that could connect the guidewire directly to the Siemens multi-channel 
preamplifier.  The preamplifier has a flex connector which was customized to have a 
BNC connector input and the wire was then connected by a handle containing the 
circuitry which can rotate freely on the connecter for necessary torque application 
(Figure 4.2.8).  This facilitated phantom testing where coaxial cable positioning and 
orientation may influence measured values particularly for device comparisons.  The 
preamplifier and adapter could be covered by a sterile bag and positioned in the sterile 
field for use.  Testing was performed to confirm that this preamplifier and adapter did not 
have an effect on device heating compared to the multi-channel preamplifier previously 
used.   
 
 
Figure 4.2.8.  Flexible adapter to preamplifier with guidewire handle to eliminate 
coaxial cable extension.    
 For the one-meter long guidewires tested, little impact was seen with changes to 
the externalized guidewire with the RF shielded or use of a floating trap.  The RF shield 
does not prevent the RF exposure at the ends of the tube.  For both options, with a large 
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portion of the guidewire inserted into the phantom, the externalized part only represents 
a small portion of wavelength in air (dielectric constant = 1) with the insulation only 
shortening that slightly.  As with prevention of RF surface burns in patients, non-inserted 
portions of devices should be kept from the edge of the bore, particularly avoiding any 
contact with bore wall, and as midline as possible to avoid any potential interactions with 
the E-field.  Again, this effect may be more pronounced in short-bore magnets 
depending on how much the E-field extends beyond the transmit coil end rungs.  
Operator contact could also slightly alter the device heating, particularly in heavily 
insulated wires.     
 In addition to being acutely sensitive to device placement, level of measured 
heating is also highly dependent on temperature sensor positioning.  This critical sensor 
positioning has also been documented in the literature (134).  We had reasonable 
repeatability in temperature sensor placement by marking the monitoring locations but 
that does not necessarily ensure proper positioning and measurement of the maximally 
heated point.  With only a few millimeters difference in positioning of the sensors in the 
final example, a 30% difference was observed and it is unknown whether that 
represented the maximum.  This motivated some of the work described in the section 
following to improve the characterization of the device heating profile particularly in these 
complex device constructions.    
 Whole body SAR values determined by calorimetry measurements were 
consistent for the scanner and phantom we used.  Ensuring the correct coil file 
parameters was critical for this scanner estimation to be accurate.  Additional 
considerations must be taken into account for the difference in applied power and SAR 
calculations that may exist between heating phantoms and animal or human 
measurements due to the variations in composition.  The phantom is a homogeneous 
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solution whereas animal and human compositions are clearly not.  This can impact the 
RF power penetration, reflection and distribution.  Measures like the root-mean-square 
of B1 (B1rms) may provide a more conservative estimate of the power since there can 
be a large variation in SAR for a given B1 applied and will depend on the individual 
composition.  Scanner manufacturers are now reporting these values as part of the new 
IEC standard development.  The amount of power deposited should be matched as 
closely as possible or overestimated during phantom testing to determine the level of 
SAR amplification due to the device and further simulation can inform the relative values 
of local SAR in the phantom testing regions and actual human placements.   
 Despite the range of heating observed in the phantom with the typical edge offset 
heating given all these variables and their interdependence, minimal heating was 
observed with anatomic configurations which were also supported with initial in vivo 
guidewire positioning with temperature measurements.  The edge of the phantom 
represents a high E-field environment that may not be experienced in vivo, particularly 
when the device is constrained to centrally located vasculature.  Heating in vivo is also 
ameliorated by blood flow and temperature regulation.  These are among the 




4.3 In vivo heating evaluation 
In this section, we aimed to better characterize and monitor potential device 
heating during normal use through in vivo studies in large swine.  We demonstrated 
initial measurements in vivo with securely attached external temperature sensors but this 
precluded the use of many accompanying devices like small catheters and would not be 
feasible to allow regular use of the device with temperature monitoring.  Our group has 
pursued modifying the device design to incorporate space for an internal temperature 
sensor which would allow real-time device temperature monitoring during regular device 
use first for evaluation in pivotal animal studies and then initial clinical trials as an 
additional safety measure and method to validate EM simulations for realistic trajectories 
in human models.  Thermistors and thermocouples have been placed in functional 
devices such as EP catheters to monitor ablation temperatures including some 
demonstrations under MRI (135-137).  These measurement techniques are less 
favorable in the MR environment but fiber-optic sensors like the ones used for the device 
testing described earlier now are available in sufficiently small constructions to be 
incorporated into the devices for a RF immune temperature measurement technique.  
We wanted to examine appropriate locations to monitor and whether the internal 
temperature measurements would provide a conservative measure of the external 
device temperature which would be in contact with the blood and tissue.   
Providing a polyimide port for a temperature sensor on the insider or outside of 
the device during development could first provide a method to efficiently determine the 
complete heating profile by moving the sensor along the entire length of the device to 
determine appropriate monitoring locations during initial testing.  Figure 4.3.1 shows a 
sample guidewire with a normal 0.035” external profile that has a temperature sensor 
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polyimide along the inner rod and proximal hub where the temperature sensor could be 




Figure 4.3.1.  0.035” Active guidewire with internal polyimide port aligned with the 
inner rod which is accessible proximally at the hub to move the sensor along the 
device.     
 
In this part of the work, we present an analysis of the internal temperature 
monitoring approach and how it reflects external temperature measurements which 
would actually impact the local blood and tissue environment.  We then demonstrate in
vivo temperature monitoring with normal device use with an internal temperature sensor 
and explore the additional reduction in heating provided by blood flow with comparisons 





Inner and outer device heating profiles and validation   
 Device heating profiles were determined to examine potential monitoring 
locations with the guidewire positioned in the phantom as described in the previous 
section.  A 62.5 micron temperature sensor (Opsens, Quebec, CN) was placed in the 
internal polyimide tube all the way to the tip.  Prior to any scanning, the temperature 
sensor first was moved along the entire length of the device to see the baseline 
fluctuations in phantom and air temperatures (Figure 4.3.2).  The moving temperature 
sensor reflected variations in the ambient temperatures with the phantom slightly cooler 
than the air with a drop where the wire exited the phantom which is more watery on the 
surface with less gel and may experience evaporative cooling to cause the brief 
temperature drop.   
 
 
Figure 4.3.2.  Absolute temperature profile reflecting ambient temperature along 




With the temperature sensor repositioned at the tip, scanning was started and once the 
temperature increase had reached a plateau, the sensor was pulled back at a near 
constant rate to determine the heating profile from the tip all the way through to the 
proximal connector end.  Internal temperature profiles were also acquired with a catheter 
covering the proximal wire as would occur during a procedure.   
Once this unmodified data had been acquired, a 0.010”ID/0.012”OD polyimide 
tube (MicroLumen, Tampa, FL) was affixed to the guidewire exterior with very thin heat 
shrink (0.00025” wall thickness, Advanced Polymer, Salem, NH) as seen in Figure 4.3.3.   
 
 
Figure 4.3.3.  Guidewire shaft with two polyimide ports placed on either side to 
measure external heating profile.
 
The guidewire was then replaced in the phantom at the same location and the 
temperature sensor moved along the internal and external polyimide tubing.  The 
location of maximum heating was determined and marked for the both the inner and 
outer sensor locations.  The sensors then were fixed at these locations before both were 
run with a 30 second baseline, 90 second of scanning and 30 follow-up.  The marked 
locations on the sensor were compared with the two sensors and marked on the device.  
This procedure was followed for 3 different guidewires and one guidewire has 3 different 
95 

external polyimide tubings added at different positions along the circumference of the 
guidewire.  Inner and outer measurements also were made at different applied power 
levels by changing the scan parameters.   The outer/inner fraction was defined as the 
maximum outer heating divided by the maximum inner value.   
 
In vivo temperature monitoring  
A guidewire with an internal temperature sensor fixed at the maximum heating 
point was used for right and left heart catheterization in Yorkshire swine.  A 100cm 
polymer catheter (Kumpe Access, Angiodynamics, Latham, NY) was used with the 
guidewire for positioning.  Measurements were made throughout guidewire movement 
as well as testing performed at certain guidewire positions where the guidewire was held 
temporarily and a baseline was acquired, followed by the start and stop of a scanning 
interval to observe the temperature increase.            
  
In vivo and in situ comparison  
 To examine the impact of blood flow and the potential heating that may be 
experienced in vivo in a low-flow area or occluded vessel, we conducted a comparison 
of the heating observed with the same device placement in vivo and then immediately 
after euthanasia.  At the end of terminal experiments, the device with attached or 
embedded temperature sensor was positioned in the aorta or inferior vena cava and 
temperature acquisitions at 2 different flip angles were performed to artificially increase 
the power.  The animal was euthanized in the scanner without any movement of the 
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animal or the device.  The temperature acquisitions then were repeated.  The heating 
curves and maximums reached were compared in the different conditions.    
 
4.3.2 Results 
Temperature Profiles  
Moving the temperature sensor through the inner and outer polyimide tubes 
provided clear profiles of the areas of areas of device heating.  The inner and outer 
profiles indicated the same regions of heating with higher values measured with the 
inner sensor.  Figure 4.3.4 shows comparable internal and external temperature profile 
for the entire guidewire length.   
 
 





The inner device profile did not change substantially with the catheter on the 
device other than slight changes in the relative heating of the junction and exit point of 
the phantom.  Profiles from the tip through the junction are shown in Figure 4.3.5 for the 
bare guidewire in the phantom and with the wire extending 5cm beyond the end of the 
catheter.  This was also done for the guidewire 15cm beyond the catheter with the same 
profile.  Changes in device heating along the wire were observed on varying insertion 
length depending on the device construction with the most noticeable changes occurring 
with decreases at the wire end and relative increases in the heating at the hypotube 
junction and exit point of the phantom.    
 
 






Inner and Outer Comparison  
The locations of maximum heating on the guidewire were the same for the inner and 
outer temperature profiles at the given placements with lower heating always observed 
with the outer temperature sensor.  The shape of the heating curves did not differ in the 
initial rise other than the maximums achieved (Figure 4.3.6).   
 
 
Figure 4.3.6.  Simultaneous inner and outer temperature measurements at 
maximum point.
 
For the guidewire with 3 external polyimide locations tested, the fraction of outer to inner 
heating varied from 66 to 79%.  The other 2 guidewires tested had slightly higher 
fractions near 80%.  The outer/inner fraction averages and standard deviations are 
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shown in Table 4.3.1 for the 3 different polyimides in the same wire as well across 3 
different wires.   
  
Table 4.3.1.  Outer/inner heating fraction.   
 3 external polyimides  on same guidewire 3 different guidewires 
 Outer/Inner Fraction 
Average 0.74 0.81 
Standard Dev 0.07 0.065 
 
With variations in power applied, the maximum levels of inner and outer heating 
decreased as expected.  The absolute difference between the two measures decreased 
linearly with applied power and maximum heating level (Figure 4.3.7).  The relative 
fraction remained fairly constant with an average of 0.76 ± 0.04 in the guidewire tested 





Figure 4.3.7.  Outer-inner fraction and absolute difference for varying transmit 
power.   
 
In vivo temperature monitoring  
The guidewires with embedded temperature sensors were successfully used to 
access the right and left heart in vivo in swine with commercial polymer catheters.  The 
temperature fiber did not impede device use or performance and the internal sensor 
provided constant temperature monitoring in vivo throughout the simulated procedures.  
Active devices require a connection to the scanner and the temperature fiber connection 
can be incorporated into the same handle for ease of use.   Figure 4.3.8 shows a sample 
temperature recording with guidewire insertion into the vascular access sheath and 





Figure 4.3.8.  Temperature change measured as guidewire is inserted into sheath 
and into animal.
 
Several guidewires were tested in vivo with no appreciable heating beyond temperature 
fluctuations seen normally under normal scan conditions for placements in the aorta and 
IVC for right and left heart catheterization.  With the central vessel locations and 
guidewire positioning, this lack of heating correlates with the typical E-field distribution at 
a minimum in the center of the bore and animal.  By increasing the power and using 
devices with known unacceptable heating profiles, we were able to observe the continual 
temperature fluctuations throughout use and demonstrate the ability of the system to 
track temperature changes during in vivo use.  Figure 4.3.9 shows the internal sensor 
temperature readings as the guidewire was moved from the end of the sheath, up the 
aorta, and into the left ventricle.  Slight heating was observed when scanning was 
started and then variations with peaks and valleys seen as the guidewire was moved 





Figure 4.3.9.  Temperature recording during LV entry with guidewire with known 
high heating.
 
With the guidewire in place around the aortic arch in the LV forming a curve, a 
temperature acquisition was run that did not produce appreciable heating beyond the 
normal temperature fluctuations which was consistent with the end of the moving profile 
seen above (Figure 4.3.10).  These curvatures at the aortic arch, however, occurred with 





Figure 4.3.10.  Temperature measurements with the guidewire positioned around 
the aortic arch into the LV with scanning for 1 minute.   
 
Insertion lengths which produced higher heating in the phantom typically occurred in the 
most central placements of the large vessels.  Fluctuations were also seen during aortic 
pullbacks in the devices with appreciable heating which may reflect these small 
increases at critical lengths.  Less favorable placements with semi-loop configurations 
and superficial vessel locations produced little heating (<0.5°C) compared to higher 
values measured in offset phantom studies.    
 
In vivo and In situ comparison  
Temperature increases in vivo were on average half of those measured in situ 
immediately after euthanasia.  This was consistent across guidewires and with the 
different input powers and maximum heating achieved (Table 4.3.2).  There was no 




Table 4.3.2.  Maximum increases in vivo and in situ and fraction difference.   
n=6 
Max Increase  
In vivo 
Max Increase 
 In situ 
In vivo/In situ 
Fraction 
Average 0.36 0.71 0.52 
Std Dev 0.17 0.38 0.071 
 
In both in vivo and in situ measurements, heating increased acutely and then steady 
state was readily reached.  With continual scanning, the temperatures fluctuated around 
the maximum value without any further increases or observable gradual cooling (Figure 
4.3.11).   
 
 




4.3.3 Discussion  
In this section, we presented an evaluation of inner temperature monitoring with 
inner and outer temperature sensor comparison and in vivo demonstration of 
temperature recordings.  Moving the temperature sensor along the inside and outside of 
the device provides a more efficient and accurate method to fully characterize the device 
heating profile and determine the areas of maximum heating.  In our experience, 
movement of the sensor by millimeters either direction of the peak points could have a 
significant effect on the values measured.  In trying to compare device constructions or 
iterations, this helps ameliorate the concerns about exact temperature sensor placement 
during trials and the true maximum points can be found and tested.  The approach of 
placing an external thin-walled tubing to enable the slidable temperature sensor could be 
adapted for testing of any device to determine the entire profile.  Afterwards, the 
standard approach of placing temperature sensors at the specific points directly on the 
guidwire could be used for confirmatory testing.  This would provide more reliable 
placement of these sensors and ensure that the proper spots are being monitored.   
Another approach we initially tried to monitor heating along the entire device 
profile was liquid crystal heat-sensitive paint (Edmunds Scientific, Tonawanda, NY).  
This could be applied to the device with little increase in profile and changes color 
depending on the temperature reached.  These paints, however, are generally water-
soluble and would come off in phantom testing if not otherwise covered.  Monitoring the 
color change during scanning is also challenging.  Thermal paint or heat-sensitive paper 
may be useful for measurements where RF current is directly injected in the device in a 
bench-top testing method.  MR based thermometry is a powerful tool for monitoring 
tissue temperatures in RF or cryoablation type therapies but is still technically 
challenging for device temperature monitoring.  The phase based measurement is 
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typically limited to temperature resolutions of 2 degrees and would need to have high 
spatial resolution to observe the heating immediately at the wire.  Additionally, the 
presence of the device in the imaging field can disrupt the homogenous field and 
accurate quantification of phase changes.  Infrared imaging may be another possibility 
but typically measures surface temperatures so modifications are necessary to make 
measurements near the device.   
We did observe slight differences in the temperature fractions measured with the 
three external sensors affixed to the same wire which could be attributed to several 
potential factors.  While we are able to determine the maximum longitudinal point, there 
may be some asymmetry in the device heating depending on the heat source and its 
location relative to the midline of the device.  Slight variations in the exact maximum 
point chosen could also contribute to this difference.  Additionally, slight differences in 
the polyimide thickness or heat shrink surrounding could also cause small fluctuations.  
As shown, the circumferential maximum point also should be considered and tested with 
sensors around the outside along with the longitudinal position particularly when the 
maximum heating point source is unclear.   
The points of maximum heating remained consistent for the conditions tested 
with and without the catheter and during failure states.  This may not be the case in 
different device designs and must be considered.  Additionally, device positioning, 
circuitry and connection status could alter the device heating profile depending on 
design.  In these cases, the areas to monitor during in vivo use may not always been the 
maximum point under all conditions and monitoring the locations where differences in 
heating are the most dynamic and present the greatest risk of maximum heating likely is 
a better approach.  In a loopless guidewire design, for example, the tip or incorporating a 








junction has a background level of heating in all positioning that may on occasion 
exceed the tip levels when they drop considerably.  However, this level of heating is 
relatively low even in extreme offsets.   
The inner and outer temperature sensor comparison indicated for the conditions 
we tested that the heating measured inside the wire did not exceed the external 
measured values.  This suggests that the inner temperature can be monitored with the 
expectation that the outer temperature which would impact the local blood and tissue 
environment would not exceed the recorded value.  The fractional difference between 
these measurements was generally consistent for varying power levels but the absolute 
differences varied linearly with power applied and maximum increases.  This might 
suggest a conductive heating model (Equation 4.3.1.  Conductive heat transfer equation) 
where the fraction is dependent on the device construction which can alter the type 
(changing k) and thickness (d) of the insulation used and the characteristics of the heat 
generating point (A).   
 










Consequently, in vivo, without any device heating, the measurements by the internal 
temperature sensor actually may be slightly lower than the external blood temperature 
since the exterior temperature will likely be higher than the inner until the values 
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equilibrate or there is minimal device heating.  Convective heat transfer from blood flow 
could further decrease the maximum levels of heating levels appreciated on the exterior 
by more quickly dissipating the heat at the guidewire surface which may further reduce 
the outer/inner fraction.  The main risk if that this relationship could be altered by 
unintended insulation defects in the device at which point the device should be removed 
from use.   
As discussed in the previous section, the local SAR environment is likely the 
most critical factor along with device insertion length and orientation relative to the 
tangential E-field.  While we tested larger swine between 100-200 lbs for many of our 
heating studies to have similar power inputs and loading on the body coil, their shapes 
and composition differ from the human (Figure 4.3.12).  Body habitus, fat versus muscle 
composition, lung shape, and positioning and size of vessels could all impact the local 





Figure 4.3.12.  Cross-sectional images of swine and human chest at cardiac base 
(top) and apex (bottom) levels with differences in muscle/fat presence, anterior-
posterior depth difference, and lung shape.
 
Fat provides a good insulator compared to the more conductive muscle to limit RF power 
penetration where as smaller vessels in a large lung field could concentrate the E field in 
that region.  Additionally, anatomical differences could also translate into varying device 
positioning relative to the tangential E-field.  Electromagnetic simulation could help to 
inform the impact of these differences and the extremes that must be considered with 
the internal temperature monitoring providing an additional ability for in vivo validation of 
simulation results in animal studies and initial clinical trials as well as an important 
safeguard.    
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Comparing in vivo and in situ heating measurements at the same location 
provided a fairly consistent 50% heat reduction with different levels of maximum heating 
and large vessel location.  These measures were taken with the device in full flow areas 
of large vessels (aorta and IVC) which likely represent the maximum benefit that 
perfusion will have in additionally reducing any perceived heating.  Since considerable 
heating wasn’t seen with device use in vivo, these fractions also only represent behavior 
up to around 1 degree of heating in situ.  They are consistent with computational studies 
of blood flow contributions which observed a similar 2-fold decrease with normal blood 
flow (138).  Given the blood flow, these temperatures also are likely only seen in the 
immediate vicinity of the device and quickly dissipate into the vast heat sink of the blood 
pool with little impact on overall core temperature.  We attempted to investigate the risk 
of vessel wall heating with device contact but high enough heating wasn’t observed in 
vivo and testing with freshly explanted tissue in a phantom to produce higher heating still 
did not produce any histologic findings.             
In summary an internal integrated temperature probe inside a conductive MRI 
guidewire appears to reflect external temperature measurements without impairing 
normal device use.  In situ animal catheterization experiments model in vivo heating 
while suppressing the heat sink effect of flowing blood, and perhaps better model use-
mode heating than in vitro measurements.  These support follow-on engineering for 
continuous temperature monitoring as a strategy to help monitor safety of active MRI 
catheter devices.    
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4.4 Device Monitoring and Dynamic Scanner Feedback Control System 
Under normal use, we have observed minimal or no heating in simulated use 
during phantom and in vivo animal testing.  Proper device use and components in device 
and circuitry design are used to reduce the potential for radiofrequency (RF)-induced 
device heating (139,140) and enable safe device performance.  Atypical device use, loss 
of device connection to the scanner, or device failure could possibly exceed such 
protection mechanisms in rare instances.  Identifying these events rapidly and altering 
scan parameters to reduce transmit power when pausing scanning may be detrimental 
during an intervention could quickly mitigate the heating risk and provide an additional 
mechanism to ensure safe device use.     
Reasonable increases in RF pulse width and reductions in flip angle can 
substantially reduce deposited power, the induced E-field and subsequent device 
heating while maintaining acceptable image quality.  The applied RF energy produces a 
B1 magnetic field perpendicular to B0 in addition to an electric field parallel to B0.  The 
flip angle produced by a RF transmit pulse is a function of its amplitude, B1, and time it 
is applied, or pulse width (Figure 4.4.1).  Increases in flip angle are directly related to the 
length and amplitude of the RF pulse (Equation 4.4.1) and the E-field is proportional to 
the amplitude.  The electric field is minimal at the center of the body transmit coil but 
increases radially outward with high fields also seen near the end-rungs and capacitors 
(141) (Equation 4.4.2).  SAR follows the square of B1 amplitude and E-field intensity 













Figure 4.4.1.  Diagram of RF pulse with amplitude and width.
 
Equation 4.4.1.  Flip angle production from RF pulse characteristics.  
  
Equation 4.4.2.  RF transmit induced electric field.
  
Equation 4.4.3.  SAR calculation.  
    
  
Therefore, RF energy deposition decreases linearly with increasing RF pulse length and, 
additionally, the associated increase in sequence TR provides a further small reduction 
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in power.  Figure 4.4.2 shows the average power applied as measured and reported by 
the scanner with varying flip angles and pulse width.      
 
Figure 4.4.2.  Average deposited power versus flip angle and pulse width (reported 
in %, 100% = original value (500 microsecond)).   
 
The TR of a balanced SSFP sequence can be increased to ~5.5ms for a 5-fold 
lengthening of pulse width without incurring too many off-resonance artifacts for typical 
cardiovascular interventions.   
In this work, we developed and demonstrate a system to monitor proper active 
device performance and provide an additional safeguard with dynamic scanner feedback 
control during MRI-guided interventions.     Signal and noise levels from the device 
channel could indicate device connection and performance status which may result in an 
increased risk of device heating.  Safety monitoring inputs such as temperature readings 
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described with the approach in the preceding part could further inform the proper 
operating status and appropriate scan parameters.   
 
4.4.1 Methods 
Sequence modifications and communication  
A modified real-time balanced SSFP sequence was used which provided a brief 
sample device noise (RF transmit off) and then signal after a 2 degree non- selective 
pulse prior to each real-time slice acquisition to confirm device connection and signal.  
Additionally the sequence included a) features for real-time adjustment of RF pulse 
length and flip angle, and b) a “fail-safe”, which was automatically activated if the 
sequence was not perpetually informed that the active device was functioning 
appropriately.  If the device or monitoring system became disconnected (and thus 
stopped sending data), the fail-safe would force the sequence into a “safe mode” with a 
long RF pulse (2500 microseconds) and a low flip angle (20 degrees) which decreases 
applied power almost 50-fold from normal acquisition parameters.  Sequence design and 
modifications done by Michael Hansen and J. Andrew Derbyshire.   
The noise and signal data were sent via a TCP/IP connection initiated by the 
scanner host to a custom LabVIEW (National Instruments, Austin, Texas) interface 
which monitored and analyzed the changes in device signal input and device 
temperature through a fiber optic sensor attached to an active device.   The LabVIEW 
monitoring tool was programmed to send a reply to the scanner confirming proper 
performance and with any changes in pulse width or flip angle to the protocol control 
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according to device status and heating.  An overview of the system architecture is shown 
in Figure 4.4.3.   
 
 
Figure 4.4.3.  Overview of device monitoring and scanner feedback system design.   
 
Temperature Acquisition and Processing  
To input the temperature monitoring data to the LabVIEW interface an adapter 
was made to relay the analog output from the fiber-optic temperature signal conditioner 
(TempSens, Opsens, Quebec, CN) to a data acquisition board (PXI-6225, National 
Instruments, Austin, TX) for digitization.  The interface was designed to be able to 
calculate a baseline temperature reading, increase from baseline, instantaneous 
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changes in successive temperature readings, and a linear rate of temperature increase 
from a moving window of the temperature data.  Additional functions to filter the 
temperature signal where implemented with options for a moving average, smoothing, 
and a median filter.    Figure 4.4.4 shows the temperature input and monitoring display of 
the system.   
 
 
Figure 4.4.4.  Temperature monitoring interface with temperature monitoring and 




Phantom heating tests of active devices were used to determine acceptable 
initial temperature increase rates to maintain device temperature increases below 
desired limits and the impact of altering scan parameters on the temperature increases.  
To provide an accurate measure of the initial temperature increase slope, a LabVIEW 
program was used to collect and analyze the temperature data which incorporated a 
function sending a command to start the scanner at a specific timepoint after the 
baseline temperature acquisition window to ensure a consistent start of the applied 
power.     
The temperature data input was used to determine the appropriate flip angle and 
pulse width to send back to the scanner.  Depending on type of monitoring desired and 
limits selected, the program could be adjusted to alter the method of scan parameter 
control.   To limit according to the rate of temperature increase rather than an absolute 
set-point, the increase rate was compared to a desired increase rate selected from the 
studies above to determine a power factor.  The relationship between device heating 
and changes in flip angle and pulse width were used to determine the relationship 
between power factor and the corresponding adjustment in scan parameters which were 
outputted for communication prior to slice acquisition.  The prior power factor was 
modified immediately if heating beyond the limits continued and could be adjusted to 
decrease appropriately if the calculated rates indicated a continual drop over a period of 
time inputted by the user.  In another iteration, the flip angle and pulse width were 
continually increased from their default low-power values (FA 20° and PW 500%) until a 
given temperature limit was reached. 
 
Device Signal Monitoring 
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For each device channel, the scanner acquired and sent 64 noise and signal 
samples over the TCP/IP connection.  The root mean square of the signal and standard 
deviation of the noise were calculated and displayed in the LabVIEW interface.  The 
fractional change in signal between each acquisition was also calculated continuously.   
Signal and noise levels were measured with varying devices under different 
conditions to select appropriate limits for system response.  Conditions tested included: 
device unplugged at connection to circuitry, component disconnected in circuitry, 
disconnected from preamplifier box, saturation pulse applied, and moving the guidewire 
in the field.    
 
Additional System Controls  
The interface was designed to immediately send a negative status report causing 
the scanner to default to the low power mode if any of the following instances occurred: 
(1) device signal/noise header and data was not fully received; (2) temperature data was 
not in range; (3) device signal dropped between during subsequent acquisitions in 
excess of user defined limit; and (4) temperature increase absolute value or rate 
exceeded user set limit.  Alternatively, the scan parameters and operating status could 
be manually controlled with user controls in the interface and a switch from auto to 
manual mode.  Figure 4.4.5 shows the display of the system checks, auto and manual 
controls, and signal/noise data.  The sequence operation can also be paused through a 




Figure 4.4.5.  LabVIEW interface displaying status and device signal monitoring 
with both automatic and manual controls.
   
4.4.2 Results 
The maximum temperature reached by a device closely correlated with the initial 
rate of temperature increase for varying flip angle and pulse width (Figure 4.4.6).  This 
data provided the fit for the power factor scaling to determine appropriate scan 
parameter changes.  With increasing pulse width, power and temperature increase 
dropped according to the pulse width increase factor to the four-thirds power.  For flip 
angle, the power and temperature increases followed the square of flip angle as 





Figure 4.4.6.  Temperature increase rate and maximum reached for varying pulse 
width with power fits.   
Device signal and noise measurements decreased significantly when the device 
was unplugged either at the device connector (MMCX) or the connection of the circuitry 
to the preamplifier (BNC).  Some signal was still appreciated with the MMCX unplugged 
as the circuitry contains some components which are tuned to 64 MHz and can act as an 
antenna.  When a series component was disconnected in the circuit box, the signal also 
fell dramatically compared to three other measures in different configurations (Figure 





Figure 4.4.7.  Device signal and noise measurements with varying connection 
states.
 
Varying scan parameters such as slice number did not significantly change the 
signal and noise measurements.  The application of a saturation pulse resulted in a 50% 
reduction in measured signal but was still differentiable from the MMCX connection drop 
of over 90% of the previous signal value (Figure 4.4.8).  Since the signal measurements 
come from the 2 degree pulse, the dynamic changes in flip angle and pulse width did not 
have a considerable effect.  Subsequently, the fraction of current signal to prior signal 
selected as a cut-off was at least 1/3 to avoid falsely engaging the “fail-safe” with the use 




Figure 4.4.8.  Signal and noise levels comparing saturation pulse application and 
sudden device connection.
 
The monitoring system quickly identified and triggered the scanner to a low 
power state before the next slice when device signal was suddenly lost, unacceptable 
temperature increases (absolute or rate) occurred, or any of the monitoring components 
were lost.  Device heating was limited successfully by controlling the acceptable 
temperature increase rate and scaling the scan parameters accordingly.  This is 
displayed in the temperature plots in Figure 4.4.9 where the same device was tested 
with and without the monitoring system active and the heating controlled by varying the 
pulse width up to 3 times the base value (changes reflected in temperature fluctuations).  
Minimal reductions in flip angle were then used if additional power drop was necessary 





Figure 4.4.9.  Device heating limited by controlling the acceptable temperature 
increase rate and varying PW and FA accordingly.
 
 Unacceptable device heating also was controlled by slowly increasing the power 
until a fixed absolute temperature increase was reached.  First the pulse width factor 
was dropped by a half-fraction from 5 to 3 and then the flip angle factor was brought 
towards 1 before the pulse width would decrease all the way to 1.  The parameters 
changed according to a user-selected input of every 3 slice acquisitions. The difference 
in heating with the limited power is shown in Figure 4.4.10 with an extreme example of 





Figure 4.4.10.  Example of system with progressively decreasing power until an 
absolute temperature limit was reached.   
 
4.4.3 Discussion  
With this system, we were able to monitor several aspects of proper device 
operation (signal, temperature changes) and dynamically alter scan parameters of flip 
angle and pulse width accordingly to adjust deposited power.  Different parameter 
optimization strategies could be used to determine the appropriate operating conditions 
and ensure safe device use without having to immediately stop scanning which may be 
detrimental in the middle of a procedure.   Ultimately this type of system also could be 
designed and incorporated into a program with just external temperature or other 
monitoring inputs which would run on the scanner host and avoid communication with 
another machine.   
To maintain temperature increases such as below 2 degrees in a short time 
period by limiting the increase requires an increase rate of less than 0.2 degree Celsius 
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per second.  Given the temperature sensor and signal conditioner accuracy of 0.3 
degrees, this may not be the preferred method or a larger time scale of change needs to 
be considered.  Considering this is a safety backup system that should only be engaged 
if necessary, we found that increasing the power slowly and ensuring that an absolute 
temperature level wasn’t exceeded during the power ramp up likely a better approach.  
This approach may also be preferable during initial clinical testing where the device can 
be moved to different locations, including those that might be considered higher-risk for 
heating, and then scanning started with the gradual increase in power to assure that 
normal scan parameters are appropriate.  The system was set-up to still respond to 
acute changes once the absolute threshold was achieved but the fluctuations while the 
device had acceptable absolute temperature readings would cause constant fluctuations 
in pulse width and flip angle values.  Since the temperature data was acquired at a much 
higher rate than slice acquisition, we were also able to look at several temperature 
measurements and monitor the trends to limit the influence of the small point to point 
fluctuations.    Determining a baseline in vivo may also be challenging with the device 
continually moving and if there are fluctuations in the local internal temperatures 
measured so a maximum temperature cut-off is likely preferred.   
The signal measurements could drop naturally as the device is removed from the 
body or in areas where signal source is low.  This is unlikely in a normal vascular 
intervention where the device is in the blood pool but could arise in other procedures.  
Removing the guidewire causes a slow reduction in signal (Figure 4.4.11) as opposed to 
a sudden drop if something is disconnected which was also factored into our response 




Figure 4.4.11.  Signal and noise levels recorded as guidewire was pulled-back 
from the aorta and out the femoral access sheath.
 
In place of these signal and noise measurements at each slice, an alternate mechanism 
to determine device connection could also be used.  A sensor could be incorporated in 
the circuit box to provide a visual cue to the operator that a power measurement is no 
longer detected and then that input provided to the scanner or system through an 
additional input.  Similar to how surface coils are monitored, monitoring the current and 
response of the PIN diode in the detuning circuitry could also be performed.   
We also conducted real-time imaging to ensure that scanning at the varying flip 
angle and pulse width parameters listed would be reasonable to guide procedures if a 
reduction in power is necessary.   Three-fold increases in pulse width could permit 
anatomic and device visualization for procedural guidance with minimal increase in 




Figure 4.4.12.  Sample cardiac images at varying flip angle and pulse width.
 
These become more pronounced with the longer TRs but image guidance is still 
sufficient to determine device position or physiological situation before pausing scanning 
to address the issue.  With decreasing flip angle, contrast between the myocardium and 
blood pool decreases and is likely not sufficient below 20 degrees.  Alternatively, other 
lower power sequences like GRE could be used to enable imaging at further decreased 
power limits than may be possible with SSFP.       
While we have demonstrated the performance of this system with temperature 
monitoring, this system could also readily incorporate other potential inputs to monitor 
and control operating parameters as new measures of device safety are developed 
(142-145).   Our group has started to examine the possibility of device-based RF power 
measurements.  One of the methods to measure RF power is a thermal sensor where 
the incoming power is absorbed by a “dummy” load, typically a resistor, and the heat 
produced by the load is proportional to the power dissipated, regardless of frequency.  
We employed a 50 ohm resistor in series with the circuitry with a temperature sensor on 
the resistor to measure heat dissipation.  Resistor heating followed the same heating 
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curves seen with the device temperature curves and increased with increasing scan 
power by varying flip angle.  For varying device heating with altering device position, the 
resistor measures did not necessarily correlate with the device tip heating.  In an 
instance where the tip heating decreased suddenly, the resistor heating actually 
increased (Figure 4.4.13).  This could indicative of an impedance of the surrounding and 
the current is preferentially dissipated at the resistor rather than the guidewire tip or a 
shift occurs where the majority of current is on the externalized portion of the guidewire 
and dissipated at the resistor and insertion point rather than at the tip of the device.     
 
 
Figure 4.4.13.  Resistor heating at various flips and corresponding tip heating at 
45 degrees with sudden change reflected in both measures.
 
Imaging based device safety monitoring methods may also be possible.  Reverse 
polarization imaging could provide an indication of device coupling that could result in an 
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unsafe condition (146).  At minimum, some comparison between the forward and 
reverse polarized image would be necessary to indicate a loss of signal or change in 
device condition because the linear dipole or other coil designs normally can produce a 
linearly polarized field.  MR thermometry is another available technique but the 
limitations discussed earlier make this challenging and unlikely for accurate real-time 
measurements with current techniques.  Alternatively, the device could potentially be 
used to receive the signal immediately near the device for potential measurements with 
a limited field of view and rapid acquisitions.     
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4.5 Chapter Summary and Contributions 
This chapter began with an evaluation of the important parameters in evaluating 
active MRI device safety which helped inform the development of improved methods 
to characterize the device heating profiles and provide a means for continual 
temperature monitoring.  Inner and outer temperature measurements were 
compared and the utility of internal temperature measurements seen with in vivo 
temperature monitoring during simulated left and right heart catheterization.  These 
components were then integrated into a system that was developed to monitor 
device status and dynamically alter scan parameters to enable a procedure to 
continue uninterrupted.  Together these contributions help elucidate the key 
components to consider for RF device safety, provide an indication of heating 
observed in large animals with improved monitoring, and an additional backup 








MRI GUIDED CARDIOVASCULAR ACCESS 
 
5.1 Introduction  
Catheter access to blood vessels is necessary prior to any endovascular 
procedure.  Initially this required surgical exposure and repair, but now typically is 
accomplished using direct palpation or anatomic landmarks.  In difficult cases, such as 
patients with peripheral vascular atherosclerosis and obesity, adjunctive image guidance 
with X-ray fluoroscopy or ultrasound can be helpful.   Standby X-ray is used frequently to 
confirm guidewire position before placing large introducer sheaths, especially when 
tactile feedback suggests an irregularity.  Complications can arise from this seemingly 
simple procedure including vascular injury or mural disruption, hematoma, 
pseudoaneurysm. arteriovenous fistula, or life-threatening hemorrhage (147).  
Percutaneous vascular access can also be difficult in research animals such as swine 
with small or impalpable vessels requiring surgical exposure at some facilities.      
The superior soft tissue visualization and multi-planar viewing capabilities of MRI 
is appealing to guide endovascular and minimally-invasive interventions.  We are 
developing real-time MRI guidance for transcatheter procedures (148).  Direct 
percutaneous vascular access inside the interventional MRI system would be an 
attractive alternative to access in the X-ray system followed by transfer to the MRI 
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system.  MRI-guided vessel access could exploit the inherent vessel contrast and 
greater anatomic context of the vessel and its path.     
The soft-tissue contrast of MRI could also allow operators to secure alternate 
access to the heart which may be required in certain cardiovascular diseases or 
procedures where traditional vascular access is insufficient.  Percutaneous direct cardiac 
access through the chest wall can provide direct targeting for cardiac structures which 
may otherwise be extremely difficult to reach endovascularly due to their location and 
orientation, to a patient’s aortic or other vascular disease, or device size or positioning 
constraints.  Image guidance for such a procedure could allow targeting of the proper 
entry site and trajectory to avoid critical structures in the entry path with close monitoring 
of the procedure and cardiac structure and function.    
In this work, we examined MRI guidance for three different type of cardiovascular 
access: (1) jugular vein; (2) transabdominal access of the hepatic and portal veins; and 
(3) transthoracic direct cardiac access, with pre-clinical demonstrations in swine.  Animal 
experiment protocols were approved by the institutional animal care and use committee, 




5.2 Jugular Access 
In a porcine model of difficult vascular access, we tested the feasibility of MRI 
with narrow field of view to guide needle access to blood vessels.   We hypothesized 
that real-time MRI needle and guidewire access to the jugular vein is feasible using 
reduced field-of-view techniques and active profiling needle devices.  We compared a 
custom “active” profiling needle with commercial “passive” MRI-compatible needles in 
procedure time and number of passes.  We also hypothesized that enhanced imaging 
guidance would enable novice operators to achieve access with proficiency similar to 
that of more experienced operators. 
5.2.1 Methods 
Vascular Access In vivo  
The active needle was evaluated in vivo during real-time MRI-guided jugular vein 
access in swine.    Animal experiment protocols were approved by the institutional 
animal care and use committee, according to contemporary NIH guidelines.   Yorkshire 
farm pigs (mean 36.3 kg ± 7.8 kg) underwent mechanical ventilation with inhaled 
isoflurane.   
 
Operators
We tested the ability of MRI to allow inexperienced operators to perform difficult 
vascular access by comparing novice (medical student), intermediate (fellow), and 




Jugular Vein Access  
Jugular vein access in swine was selected as a model of difficult vascular access 
because pulses are typically not palpable, anatomic and radiographic landmarks are 
limited, and the veins readily spasm when irritated and collapse under superficial 
pressure (149).  A total of 30 vessel access procedures were attempted (average vessel 
size 0.81 ± 0.09 cm), 17 with the active needle (average vessel size of passive needle 
attempts 0.80 ± 0.09 cm) and 13 with the passive needle (0.81 ± 0.10 cm).  Most access 
attempts were to the external jugular vein, except in the larger animals where the 
internal was accessed to have similarly sized targets, since unlike humans, the external 
is larger and more superficial than the internal jugular (~0.4cm in diameter for the pigs 
used) and often used for catheterization in many animals (150).  When possible, bilateral 
access was attempted in the same animal by a given operator for comparison of active 
and passive needle use as described later in this section.     
To identify the vessel target and plan the desired trajectory and entry location, 
three orthogonal stacks of free-breathing, non-gated T2-weighted SSFP scout images 
were acquired of the neck region.  From these images, an entry site was selected where 
a straight vessel segment was clearly visualized that was suitable for vascular access 
and that had limited tortuosity and bifurcations.   A sample scout image for vessel 
identification and slice positioning is shown with the real-time 3D slice rendering in 





Figure 5.2.1.  Procedure workflow.  Scout images (A) used to identify vessel entry 
sites and then place real-time slices (B) with water-filled syringe identifying 
trajectory.
 
For better visualization of the vessel during the access procedure, the field of view was 
reduced without aliasing using a small 7 cm diameter loop coil (Siemens Medical, 
Erlangen, Germany).  The coil was placed in a sterile bag and positioned by the operator 
just caudal to the desired access site.  This allowed the field of view to be reduced to 
229 x 135 mm without aliasing while maintaining the same matrix size, increasing the in-
plane resolution to 1.2 x 0.94 mm and providing good signal with the close proximity of 





Figure 5.2.2.  Access set-up and imaging.  (A) Photo of neck access site, prepped 
with small loop coil in sterile bag.  Examples of imaging with (B) and without (C) 
small loop coil and reduced field of view.
 
Two constantly updating perpendicular long-axis slices along the vessel were 
used in the sagittal and coronal directions to provide cranial-caudal, anterior-posterior, 
and right-left positioning of the needle relative to the target vessel.  A third short axis 
slice perpendicular to the vessel was also used occasionally for positioning and to 
confirm vessel entry by the needle.    The operator then used an MR visible pointer 
(finger, Gadolinium or water filled syringe, or active needle) at the animal’s neck area to 
locate the desired entry point and needle trajectory.  The scan positioning and targeting 
was adjusted during the procedure if necessary by an operator in the control room.   
For the active needle, a device-only projection mode with non-slice selective 
imaging of the device channel only available in the real-time reconstruction system was 
used (6).  This assisted initial trajectory planning to align the needle to the imaging slice 
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(Figure 5.2.3) and to identify efficiently the location and trajectory of the active needle if it 
was out of plane.   
 
 
Figure 5.2.3.  Device-only projection mode enables visualization of entire needle 
length to help align trajectory to imaging plane.
 
Previously-acquired time-resolved magnetic resonance angiograms were also 
available to assist in slice positioning and serve as a roadmap in the 3-D rendering in the 
real-time display (6) .    Vessel entry was confirmed by imaging, by gadolinium 1% 
angiography, and by successful insertion of a guidewire into the lumen down towards the 
right heart.  Finally, the needle was exchanged for a standard introducer sheath, 
securing access to the vessel.       
 
Active and Passive Needle Comparison  
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Access was attempted bilaterally on a total of 12 animals with either the active 
needle design or the unmodified passively visualized needle, for a total of 24 access 
attempts.  The planning and imaging approach described above was the same for the 
active and passive needle attempts, other than only the active needle being visible at 
skin entry.  To minimize the influence of which needle (active, passive) or side (right, left) 
the operator started with, operators alternated both the type of device and the side that 
access was attempted initially. 
 
Endpoints and Statistical Analysis  
Needle puncture of the vessel with blood return and advancement of a guidewire 
for sheath exchange within 15 minutes of skin entry was defined as a successful 
vascular access attempt.    Success rates, procedure time and number of passes 
needed to access the vessel were compared between attempts with the active and 
passive needles.  Procedure time was considered from first skin puncture to successful 
placement of a wire into the vessel.  A needle pass was defined by an attempted vessel 
puncture.     The time-based success measures were not normally distributed, 
particularly given procedure failure.  Therefore we used non-parametric, unpaired 
statistical tests (Fisher’s Exact Rank for Success Rates and Mann-Whitney U for time 
and passes) to compare the procedure outcome measures for the active and passive 
needle attempts.  Parameters are reported as mean ± one standard deviation with two-






Real-time MR imaging enabled careful selection of the skin and vessel target site 
and visualization of the vascular access and guidewire placement.  Use of a small 
receive coil at the surface helped maintain the sterile field and allowed reduced field of 
view imaging without wrap-around artifacts for better visualization of the target vessel 
during the procedure.  Representative procedure images with the skin trajectory and 
needle access with the active needle are shown in Figure 5.2.4.   
 
 
Figure 5.2.4.  Active Needle in vivo.  (A) Planning trajectory with needle on skin 
surface.  (B) Entire needle length and tip location clearly visible.  (C)  Distal 2 




The needle device performed as expected, allowing blood return, gadolinium 
angiography, and wire passage through the 0.035”-guidewire-compatible central lumen.  
Increase in coil signal was also apparent when the vessel was entered, corresponding to 
the increase in available signal source.   
Operators were marginally more successful in achieving jugular vein access 
within the allocated 15 minutes using the actively visualized needle than the passive 
needle.  Successful attempts using the active needle were shorter and with fewer needle 
passes than those using a passive needle.  For all access attempts, 12 of 17 (71%) 
active attempts vs.  8 of 13 (62%) passive attempts were successful, p=0.71.  The 
results for the subset of 12 animals with bilateral access attempted systematically in 
each animal are shown in Figure 5.2.5 where access was achieved in 10 out of 12 
animals (83%) with the active approach and 7 of 12 (58%) for the passive, p=0.37.   
Among successful procedures, average time-to-access was shorter using the active 
needle (88 vs. 244 sec, p=0.022), and required fewer needle passes (4.5 vs. 9.1, 
p=0.028).  Including all access attempts, and censoring failure attempts as time to 
access of = 900 sec and number of passes = 15 since rank-based statistics were used, 
the differences between active and passive approaches for number of passes (p = 





Figure 5.2.5.  Access results in 12 animals with bilateral attempts comparing 
active and passive needles in success rate, time to access, and number of needle 
passes.
 
Operator experience did not have a clear impact on the success or duration of 
the access procedures although operator subsets were small (Figure 5.2.5).  Results 
were more variable with the passive needle attempts than active needle ones.   In the 
animals with bilateral attempts, intermediate and advanced operators were successful 
on all active attempts while the two failures by the novice occurred (1) in the first 
procedure and then (2) during a later attempt when wire placement was unsuccessful 
after vessel access (bleedback).  Time to access and number of passes in the 
successful procedures with the active needle also did not correlate with experience and 
were similar between groups.  For passive needle access, the novice operator was more 
successful and quicker than the intermediate and advanced operators which were more 
variable.  Expert operators provided a subjective report that the MRI-compatible needles 




Table 5.2.1.  Access results comparing novice, intermediate, and experienced 
operators for success rates, average time to access and needle passes with active 




MRI-guided vascular access was accomplished with both actively and passively 
visualized MRI-compatible needles.  When actively or passively visualized needles are 
perfectly aligned with the imaging plane (Figure 5.2.6) the tip position is evident.  
However, in our experience with a slightly longer (15 cm) and more flexible needle, this 
was not always the case and accounted for much of the extra time spent during the 
passive needle attempts.  Several algorithms to better track passively visualized devices 
including needles are under development (151) which may assist the procedure.   
 









Passes Time (sec) 
Novice 5 60 4.3 ± 1.5 
99.0 





Intermediate 3 100 4.0 ± 2.6 
94.3 
± 60.1 33 13.0 424.0 
Advanced 4 100 4.8 ± 2.6 
105.8 








Figure 5.2.6.  Passive Needle in vivo.  Exact tip location is visible when aligned in 
plane (A) but difficult to locate if part of the needle is out of plane (B).
 
MR imaging provided greater information to the operator about desirable vessel 
entry site and multi-planar views of the vessel and needle position typically unavailable 
with other imaging modalities.  This enhanced imaging may have assisted operators with 
little to no experience to successfully achieve vascular access by providing a greater 
anatomic context and proper needle positioning and approach to the vessel.  In our 
experience, the operator’s technique had the biggest impact on successful outcomes, 
particularly with the passive needle.  Maintaining a good long-axis imaging slice of the 
target vessel and aligning the needle accordingly along that trajectory greatly simplified 
the procedure.  This approach required minimal movement of the imaging slices and 
time spent searching for the needle location.  It also helped ensure that the operator did 
not take an oblique angle to the vessel that may cause later difficulty in passing a 
guidewire or sheath.   
Use of the active needle and device only projection mode facilitated aligning the 
needle to the appropriate slice and trajectory before skin entry as described in the 
methods.  We also pursued the use of a needle guide and MRI-compatible device holder 
to help the operator identify and maintain the device positioning.  A photo of the arm and 
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holder set-up is seen in Figure 5.2.7 with accompanying MR imaging.  This helped align 
the needle to the long-axis slice along the vessel and water-filled needle guide was 
apparent on MR imaging which could be used with either the active or passive needles.  
Without finer manipulation of the holder at the distal end, it was slightly more challenging 
to change the angulation of the needle as necessary during the procedure for vessel 
entry and subsequent wire exchange.   
 
 
Figure 5.2.7.  Device holder and needle guide.  Photo of set-up in (A) with needle 
guide appearance with active needle seen on real-time MR imaging in (B).   
 
The minimal difference between novice and more experienced operators in 
achieving access, particularly with the passive needle, also may be attributed to those 
less familiar with access and other adjunct imaging being more likely to follow the 
imaging planes and technique described above to orient the needle trajectory in long-




MRI also offers other potential enhancements that might simplify complex 
procedures, monitor complications and confirm procedure success.  Previously acquired 
MR angiograms may provide enhanced roadmaps combined with real-time imaging 
slices in the 3D-visualization window (Figure 5.2.8).   
 
Figure 5.2.8.  MR angiograms of neck vasculature displayed as dynamic MIP in 
real-time system 3D display.
 
Fluid accumulation or extravascular hematomas can be quickly recognized and 
treated without delay typical of X-ray workflows to administer exogenous contrast.  
Avoiding inadvertent needle entry to bystander structures could potentially reduce 
complications.  In our experience, we observed one intraprocedure hematoma formation 
after unsuccessful needle passage but no inadvertent carotid punctures.  Selective 
gadolinium injections after imaging saturation permit additional confirmation of vessel 
entry.   
Procedural performance could be improved with superior vessel and device 
visualization.  In addition to the material considerations mentioned, tip location and 
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targeting accuracy are limited during the procedure by the distance between the start of 
the coil and the true needle end necessitated by the long bevel.  Visualization of the 
signal can appear larger than the needle size which may make targeting small vessels 
for access more challenging.  Tracking may assist in the localization but millimeter-scale 
errors are still possible and the coil is not located exactly at the end of the needle tip.  
Signal can also be lacking in low signal tissues where an internal signal source may be 
necessary.   As with any active device in the MR environment, RF safety and heating 
must be considered.  Detuning during RF transmission and cable traps are already used 
to reduce the coupling to the high-power RF B1 deposition.  Further design modifications 
could also be employed to reduce the heating risk in these short needle type devices.   
In addition to a more defined device appearance, improvement of the real-time 
vessel imaging would further facilitate this procedure.  We improved the small vessel 
imaging in real-time using a small local receive coil to permit a reduced field of view but 
spatial and temporal resolution closer to that of ultrasound would make the MRI-guided 
approach more comparable, particularly for smaller vessels.  Alternate non-cartesian 
trajectories like radial or spiral may allow increased temporal resolution to observe 
vessel deformation and then greater spatial resolution could permit targeting of smaller 
vessels.  The logistics of the MR environment are more complicated than alternate 
imaging techniques (ultrasound, X-ray) but the neck was relatively accessible and this 
would permit vascular access in a procedure already being performed in the 





5.3 Transhepatic Vascular Access 
Transhepatic access can be used when typical venous access is not available or 
insufficient such as in small pediatric patients with venous occlusion for multiple 
procedures (152-154).  Clinically, this is performed under X-ray with progressive needle 
advancement and contrast injection or with limited views under ultrasound guidance 
(155).   This approach can also enable alternate approaches to procedures like TIPS 
where PIPS or percutaneous intrahepatic portosystemic shunts have been attempted in 
place of the transjugular approach with x-ray, ultrasound and electromagnetic tracking 
guidance (156-158).  The easily visualization of vascular structures with MRI could allow 
a more targeted approach for these procedures avoiding contrast and x-ray exposure 
and clearly identifying and avoid nearby soft-tissue structures.  We hypothesized that 
MRI guidance could facilitate percutaneous transhepatic access to the hepatic and portal 
veins.      
 
5.3.1 Methods  
MR Imaging and Active Devices  
All imaging and interventions were performed in a short, wide bore Siemens 
Espree 1.5T MRI scanner (Siemens Medical Solutions, Erlangen, Germany) with surface 
body matrix receive coils (TIM) in addition to the independent active device channels.  
Access was achieved beneath the abdominal coil or through one of the coil openings  
Real-time balanced steady-state free precession (SSFP) imaging (TR = 3.67 ms, TE = 
1.23ms, ST 6mm, FA 45°, matrix 192x144, FOV 340x255mm) with a separate real-time 




Liver Imaging and Trajectory Planning  
Accessible hepatic and portal vein branches were identified on MR imaging that 
could be reached from an anterior, sub-xyphoid approach in swine.  Sample vessel 
imaging is seen in Figure 5.3.1.   
h 
Figure 5.3.1.  Target liver vessels seen in coronal (A), transverse (B), and sagittal 
(C) views displayed with relative 3D positioning in (D).  Red arrow indicates 




The active needle was used for access of the hepatic vessels.  Trajectories were 
selected to avoid the rib cage, stomach, gall bladder and central portions of the portal 
vein which may be extrahepatic.   
 
5.3.2 Results 
The abdominal access point was selected to enter sub-xyphoid and avoid 
puncturing the stomach seen in black on the imaging.  The needle positioning was then 
redirected after entry as necessary to reach the desired vessel.  A small branch of the 
portal vein was successfully accessed with Gadolinium injection and wire placement for 
confirmation (Figure 5.3.2).   
 
 
Figure 5.3.2.  Success portal vein branch access.  Needle entry position seen in 




The active needle tip visualization provided valuable positioning assistance and 
clear indication of hepatic vein access.  Figure 5.3.3 shows the approach to the hepatic 
vein where the tip of the needle traveled inferior of the vessel out of plane which was 
evident by the lack of the closely located distal marker points.  This was corrected to 
readjust the path to successfully puncture the vessel.    
 
Figure 5.3.3.  Active needle facilitating hepatic vein access.  Needle tip was out of 
plane in (A) but positioning was corrected and vessel accessed in (B).  
 
The presence of the distal marker points in the coronal view of the vessel provided 
confirmation of vessel entry in addition to Gd injection through the needle and wire 




Figure 5.3.4.  Confirmation of hepatic vein access.  Distal markers are seen in 
coronal view of hepatic vein branch (A) and wire passage into IVC towards the 
right heart (B). 
   
5.3.3 Discussion 
In this part we were able to apply the capabilities of MRI and the approaches 
developed in jugular aspect of this work to enable more complex vascular access.   MRI 
guidance provided clear imaging of the hepatic vasculature.  This procedure as well as 
TIPS and other vascular liver interventions could benefit from additional MR angiograph 
roadmaps similar to those seen for jugular access.  For these procedures, they can 
provide the locations of neighboring vascular and ductal structures that may be at risk 
during the procedure like the hepatic artery and bile duct.  Figure 5.3.5  shows an 
example of the 3D rendered MIPS of the hepatic and portal veins and hepatic artery 
(159).  Additionally, a magnetic resonance cholangiogram (MRCP) could be acquired 




Figure 5.3.5.  3D Rendered MIPS of hepatic veins and artery with real-time slices 
for enhanced guidance.
 
The greater anatomic context enabled a targeted approach from the abdominal 
wall to the target vessel.  Upon entry the rightward portion of the stomach was avoided 
and the needle could be clearly directed towards the target vessel.  Access with a 
passive needle may have been possible with the contrast against the liver parenchyma 
but these were typically long trajectories and the needle could easily go out of plane as 
was demonstrated by the earlier figure with the active needle tip placement.  Shorter 
trajectories may also be possible depending on the approach and usingthe initial MR 




5.4 Transthoracic Direct Cardiac Access 
Percutaneous direct cardiac access through the chest wall can provide direct 
targeting for cardiac structures which may difficult to reach endovascularly.    We 
hypothesized that image guidance provided by MRI for percutaneous cardiac access 
could allow targeting of the proper entry site and trajectory to avoid critical structures in 
the entry path with close procedural and functional cardiac monitoring.   Using MRI 
guidance, we demonstrated a planned and monitored procedure to right and left 
ventricular puncture in swine using a closed chest transthoracic approach. 
5.4.1 Methods 
Animal experiment protocols were approved by the institutional animal care and 
use committee.   Yorkshire farm pigs underwent mechanical ventilation with inhaled 
isoflurane.   
 
MR Imaging and Active Devices  
Body flex and spine array coils were used for receive and access was achieved 
beneath the chest coil or through one of the coil openings.     
MR Angiogram (MRA) 3D Rendering   
MRA was acquired with a breath-held 3D FLASH sequence with the following 
parameters: TR = 3.08 msec, TE = 1.02 msec, FA = 25°, FOV = 400 × 400 mm, and 
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voxel size =1.6 × 1.0 × 1.6 mm.  Dicoms were exported to the real-time reconstruction 
system where they are dynamically rendered as a maximum intensity projection (MIP) in 
the 3D rendering window with the real-time imaging slices.   
Black-blood Ventricular Septal Defect Roadmap  
Roadmap displaying the ventricular septal defect target location was a dark-
blood prepped 4-chamber turbo-spin echo (TSE) acquisition (TR = 700 msec, TE = 33 
msec, FA = 180 degrees, ST = 5 mm, FOV =  340 mm x 276 mm, and Matrix = 256 x 
154, Acceleration 2).   
Myocardial Delayed Enhancement 3D Rendering   
A stack of delayed enhancement images of the myocardium were acquired 10 
minutes after Gadolinium administration with the following parameters: FOV 340x276, 
ST 8mm, TR 700 ms, TE 3.23 ms, FA 25 deg, TI 300 ms, matrix 255x192, BW 140 
Hz/Px.  The myocardium was manually segmented in Syngo software (Siemens) and 
display adjusted to show the enhanced areas.  The images were then displayed in the 
3D rendering window as a dynamic MIP as described previously for the MRA.  
 
Direct Cardiac Access  
Closed-chest perventricular cardiac access was attempted to the right and left ventricle 
using the actively visualized needle.  In planning the trajectory, we employed both 
real time imaging views and previously acquired MR roadmaps and angiograms to 
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select an appropriate entry site and path to the desired target.  An access trajectory and 
corresponding imaging planes were selected that would allow safe needle entry and 
avoid critical structures.  An MR visible marker (syringe w/water or Gadolinium) or the 
active needle could be visualized externally to identify and align to the selected 
trajectory.  Right ventricular access was performed through the right ventricular free wall 
through an intercostal space parasternally (Figure 5.4.1).   
 
 
Figure 5.4.1.  Right ventricle access trajectory in short-axis (A) and angled coronal 
(B) views.   
 
Apical access to the left ventricle was attempted from a sub-xyphoid approach for 
targeting aortic and mitral valve structures (Figure 5.4.2).  Depending on the orientation 
of the heart and placement of the apex, the chest wall could be entered from either the 





Figure 5.4.2.  Left ventricle apical access trajectory in sagittal (A) and angled 
coronal (B) views.
 
The marker then was replaced with active needle to reconfirm the trajectory and prepare 
for access (Figure 5.4.3).   
 
 




Slight adjustments to the trajectory were made if necessary due to limitations on rib 
space or xyphoid positioning.  Two real-time imaging long-axis slices along the needle 
provided positioning during entry.  A short-axis slice was used to monitor cardiac 
function and entry of the needle into the proper chamber.  Cardiac access was 
confirmed visually on MR by needle location in the appropriate ventricle, with aspiration 
of blood through the needle and non-selective saturation followed by Gadolinium 
injection through the needle.  After acute non-survival procedures and after follow-up for 
survival procedures, the explanted hearts were examined for damage to surrounding 
tissues during needle entry.   
 
Pericardiocentesis  
The fluid-filled pericardial space was approached with the active needle in a 
similar approach as the direct cardiac puncture and position was confirmed with 
gadolinium injection or guidewire placement.  Fluid was then drained through the needle 
or replaced with a guidewire exchange for a pericardial drain.   
5.4.2 Results 
An initial needle trajectory was selected prior to skin puncture from an accessible 
entry location and adjusted as necessary during passage through the chest wall and into 
the heart based on the real-time imaging information.   
To avoid damaging structures such as the internal thoracic (mammary) arteries 
while entering the chest wall, they were displayed as MRA MIP in the 3D display window 
with the real-time slices.  Right-left positioning was adjusted to prevent possible puncture 
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which was typically lateral to the RIMA for RV access and medial to both vessels in LV 
access (Figure 5.4.4).      
 
 
Figure 5.4.4.  Internal thoracic artery MRA displayed in 3D rendering with slice 
positioning for LV (A) and RV (B) access.   
 
For right ventricle puncture, the entry level was selected based on real-time 
imaging planes and available intercostal entry space to stay below the atrioventricular 
valve plane and minimize lung traversal.  Imaging also helped to confirm that the angle 
of the needle and tip maintained a trajectory towards the apex of the heart rather than 
angled up towards the tricuspid valve.  Figure 5.4.5 shows an example of right ventricle 
puncture with the active needle and the multiple views along the needle trajectory 
available to the operator.  We monitored access in two views as can be seen to allow 





Figure 5.4.5.  RV access shown in multiple views and 3D display targeting defect 
marked by white arrowhead.  Lung traversal was minimized and angulation of 
needle up towards AV valve was observed and could be corrected.      
 
Sample target pathology, a muscular ventricular septal defect, was displayed 
clearly in previously acquired black blood image roadmaps in the 3D display window 
along with real-time imaging slices in which the defect also was apparent.  Initial chest 
wall entry placement was aimed to the defect when possible and adjustments were 
made during needle passage into the ventricle to reach the defect (Figure 5.4.6).  In this 






Figure 5.4.6.  Targeting muscular VSD with blackblood roadmap to help align 
initial trajectory (A) and aiming needle at defect in (B).   
 
Left ventricle access was typically approached just lateral to the true cardiac 
apex and angled to reduce the myocardial path length. During entry into the left 
ventricle, care was taken to avoid inadvertent puncture of the papillary muscles, 
particularly posterior.  These were visible on scout imaging and real-time slices so an 
angle was chosen to enter the left ventricle between the papillary muscle and 
interventricular septum.  The needle tip was carefully advanced and positioned also to 
not risk puncturing the septum while directing the needle towards the LV outflow tract.  






Figure 5.4.7.  LV access while targeting aortic valve (A) and avoiding the 
interventricular septum (B) and papillary muscles (C). White arrow –  papillary 
muscle.  Red arrow – interventricular septum.  Arrowhead – needle tip.   
 
In cases where a previous area of scar from myocardial infarction was targeted, 
the real-time MRI slices demonstrated the thin walled regions which were additionally 
confirmed by the 3D rendering of the prior delayed enhancement acquisitions (Figure 





Figure 5.4.8.  Targeting infarcted region of LV.  Thinned region seen on real-time 
slices (A-C), marked by blue arrow and corresponding delayed enhancement seen 
on 3D rendering (D,E), displayed in blue.   
 
Real-time MRI with the active needle also permitted successful pericardial and 
pleural fluid drainage.  Fluid signal was apparent on MR imaging and the operator was 
able to select an appropriate needle path particularly in effusions that were not global 




Figure 5.4.9.  Pericardial access.  Accessing the lateral pericardial space (A) with 
injection of Gadolinium to confirm entry (B).
5.4.3 Discussion 
 MR imaging enabled careful planning of a preferred trajectory for transthoracic 
cardiac puncture.  We utilized several different MR acquisition techniques including real-
time imaging, MR angiography, and other specialized acquisitions to create clear 
roadmaps.  The greater anatomic information helped the operator avoid important 
vascular and valvular structures along the path.  During the access procedure, changes 
in needle positioning were quickly identified in the real-time imaging from its active signal 
and the ability to use features like device-only projection mode to quickly locate the 
needle tip.        
Some perventricular procedures have been attempted with open-chest and 
hybrid surgical approaches (160) or closed-chest under X-ray (161).  These represent 
potential applications for the MRI-guided approach and demonstrate the advantages of 
it.  Surgical chest wall access can cause considerable pain and convalescence for the 
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patient.  X-ray provides very little information about the cardiac anatomy other than 
contrast shadows.  Structural heart disease and electrophysiology procedures can gain 
tremendous benefit from MRI for imaging of anatomic targets and employ this approach 
to safely reach them if alternative cardiac access is desired.  This approach is also used 
selectively for catheterization access in patients with prosthetic heart valves with limited 
X-ray and ultrasound guidance and multiple punctures have been shown to increase the 
risk of complications (162,163).  Superior image guidance and precise needle 
positioning could enable single-pass access.  In most of the access procedures we 
performed, only one myocardial wall pass was required other than instances where the 
trajectory was altered enough by the natural needle movement to warrant repositioning.  
Aside from cardiac procedures, other non-traditional cardiovascular access sites could 
be pursued under MRI guidance.  Translumbar aortic punctures may also be feasible.   
We initially tried to achieve cardiac access using a commercially available 
passive needle but found this unsatisfactory with current devices and imaging tools.  
Passive devices typically rely on signal voids to be seen so the ability to visualize these 
passive artifacts is limited.  In some of the trajectories used for right ventricle access, the 
needle artifact was quite prominent due to the perpendicular position relative to the bore 
of the magnet.  Figure 5.4.10 shows an example of RV access attempted with a passive 
needle and the post-mortem examination which showed inadvertent puncture of the 





Figure 5.4.10.  RV access with passive needle.  Needle tip position is unclear in 
both slice views (A, B) which resulted in advertent septal puncture evident in post-
mortem examination (C).
 
Furthermore, the additional time necessary to identify needle location, particularly 
in off-target punctures, as seen in the jugular access portion of this work may be 
detrimental in this high-risk location with considerable cardiac and respiratory motion.  
Improving the conspicuity of passive device signals and developing tracking algorithms 
may help and permit these devices to be used (164,165).   Active device safety is also 
an active area of research as discussed earlier where interrupted transmission lines and 
optical approaches may help ensure safe devices.       
For safe percutaneous cardiac access, avoidance of the coronay arteries is also 
critical.  Spatial and temporal resolution limitations of MRI make coronary imaging limited 
with this technique but this could be addressed with the use of fusion of complementary 
alternate image guidance.  CT coronary angiography can provide non-invasive three-
dimensional imaging of the coronary arteries.  A CT study conducted prior to the MR 
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procedure could be co-registered with the real-time MRI and serve as a roadmap to 
avoid injuring these vessels (121).   
Information from MRI also is limited in the lung traversal part of this approach 
because of the lack of proton-containing signal.  The needle can typically still be 
visualized in these low signal areas but the addition of an inherent signal source may be 
superior.  Other than incorporating optical visualization through an endoscope or similar, 
there is not a particularly good method for lung tissue imaging.    Additionally, while we 
attempt to minimize passage through lung tissue and have not experienced specific lung 
problems, approaches may need to be pursued such as using sealed ports or intentional 
lung collapse prior to prevent potential pneumothorax.     
MRI also permits close monitoring and potential for quick intervention if 
necessary.  Cardiac motion was followed on the imaging slices, particularly in the short-
axis view which was dedicated primarily to cardiac monitoring.  As seen in Figure 5.4.11, 
any pericardial or pleural fluid accumulations could be rapidly identified and also treated 





Figure 5.4.11.  Complication monitoring taking advantage of inherent MRI 
contrast.  Pericardial (A) and pleural (B) fluid accumulation can be easily 
recognized and treated.
 
MRI techniques such as tagging or myocardial velocimetry could also be used to 
evaluate the impact of this procedure on regional wall motion.   
Pericardiocentesis is performed clinically with a blind approach or with X-ray or 
ultrasound imaging to guide or confirm pericardial puncture.  MRI offers superior 
visualization of the pericardial fluid accumulation and its specific distribution without any 
exogenous contrast.  While global effusions may be readily accessible from any 
approach, reaching an area of isolated fluid can be more difficult without adequate 





5.5 Chapter Summary and Contributions 
In this work, we first demonstrated successful real-time MRI guided vascular 
access in swine.  MRI-guided vascular access could enable procedures to be performed 
entirely in the MR suite with greater anatomic information.  Access was achieved with a 
newly developed active visualization needle and passive comparator using reduced field 
of view imaging.  Compared with a passive needle, the active “profiling” needle had a 
signal profile that permitted rapid and clear device and tip localization and which resulted 
in higher success rates and shorter procedures.   Operator experience did not 
significantly impact success rate; by contrast, operator technique in selecting and 
following trajectory plans proved important.   
This approach also permitted more complex percutaneous cardiovascular access 
where enhanced image guidance is necessary for such procedures to be performed 
safely.  MRI guidance enabled a planned and closely monitored approach for more 
challenging cardiovascular access.  Transhepatic vascular access built on the 
experience from jugular access and used the unique vessel contrast of MRI to efficiently 
access the hepatic and portal veins in swine.   
For direct cardiac access, targeting both right and left ventricle access in swine, 
skin to cardiac entry trajectories were selected based on previously acquired MRI 
roadmaps in conjunction with real-time imaging to minimize path lengths, avoid critical 
structures, and target distinct pathologies.  Real-time MRI with an actively visualized 
needle enabled continual monitoring of needle position and adjustment of the path as 
necessary.   MRI also permitted pericardial puncture for pericardiocentesis, particularly 
in localized effusions.  Overall our active needle combined with real-time MRI provided a 
169 

versatile tool for conventional and novel cardiovascular access that may have utility in 








6.1 Project Summary 
This work provided a comprehensive look at the different components necessary 
to bring MRI-guided cardiovascular interventions closer to a clinical reality.  In the first 
part, we address the lack of compatible devices and demonstrated how local coil 
designs could be implemented in functional devices with active visualization to permit 
evaluation of several different cardiovascular interventions.  An active needle with 
elongated loop coil provided clear tip positioning and markers of needle shaft positioning 
and depth.  For better visualization of cardiac occluder delivery, incorporating the device 
in a loopless delivery cable design gave the operator greater confidence in device 
deployment and positioning.  In exploring extra-anatomic bypass procedures like TIPS, a 
concentric nitinol hypotube design formed the components of a loopless antenna to 
provide the ability to position and advance an excimer laser while visualizing device 
curvature and orientation.  We also developed methods to evaluate these devices and 
their imaging performance to accurately guide interventions.  We then demonstrated 
their utility in vivo during deployment in preclinical feasibility experiments.   
Having developed a set of MRI devices, we also undertook experiments to 
understand further the parameters that impact the safety of these devices, and then set 
about to develop a feedback system to control or mitigate heating.  Through initial 
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phantom studies, we were able to identify key parameters and important considerations 
for future device evaluation of RF safety.  Effects of device positioning were 
demonstrated in addition to the variability that could be introduced with accessory 
devices like coaxial cable during phantom testing.  Evaluations of SAR enlightened 
considerations for testing conditions to simulate realistic power deposition to correlate to 
in vivo use.  By incorporating internal temperature sensors into device prototypes, we 
were then able to evaluate this potential monitoring technique as a method to more 
accurately characterize the heating profiles of complex devices and provide a unique 
temperature monitoring ability.  We also used this approach for evaluating device 
heating in vivo and in situ in large animals to demonstrate the level of heating in 
simulated use conditions and the contribution of blood flow to heat dissipation.  The 
temperature tracking and additional device monitoring capabilities then were 
incorporated into a dynamic scanner feedback control system to offer added patient 
safety during initial clinical trials. 
In the final part of this work, we demonstrated the utility of MRI guidance to 
enable traditional and complex cardiovascular access.  For central vessel access, we 
developed an imaging approach and procedure workflow to enable vascular access 
within the MRI suite.  Comparison of actively and passively visualized needles during 
jugular access in swine revealed the benefit of active visualization in slightly improving 
success rates with significant reductions in the procedure time and number of needle 
passes.  Enhanced imaging guidance also enabled less experienced operators to have 
similar outcomes as those who regularly achieve vascular access.  Similar approaches 
were used with the active needle and MRI guidance to permit trajectory planning and 
closely monitored complex cardiovascular access with transabdominal hepatic vascular 
access and transthoracic direct cardiac access.  Successful access was performed to 
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the hepatic and portal veins using the active needle with MRI informing the approach 
with constant visualization of the vessels without the need for contrast and ability to 
avoid inadvertent puncture of other nearby structures.  Direct cardiac access to the right 
and left ventricles were performed with a planned approach that allowed safe entry to 
the heart.  This may offer a potential alternative to surgical access for a variety of 
structural heart and other interventions where current endovascular approaches are 
insufficient.                    
 Together, this work provided the requisite actively visualized devices, considered 
device safety and approaches to improved testing and monitoring, and finally 
demonstrated and evaluated the ability of MRI guidance with active devices to perform 





6.2 Future Directions 
 
Interventional MRI device development will continue to benefit from further 
improvement in manufacturing techniques and more important, continued miniaturization 
of electronic components for active device development.  While cell phone, RF 
identification, and other communication technologies have substantially reduced the size 
of many commercially available elements, they are often still too big for devices that 
might fill constructions that are as small as 1 mm or less in the case of guidewires.  
Microfabrication techniques can produce relatively low-cost coils with embedded tuning 
components and potentially offer miniaturized transmission lines with switches, traps, or 
other components to further ensure safe device performance in the MRI environment 
(166-168).    Incorporating distal on board preamplifiers and optical converters could 
enable optical transmission to the scanner and reduce challenges with wire lengths and 
coupling.     Novel polymer constructions could also help limit the need for conductive 
materials used in traditional devices like guidewires and catheters.  Image-based 
visualization techniques could also change the requirements for device characteristics 
and consequently design. 
With these continual advances in device design and manufacturing, device safety 
will continue to improve as well.  The experimental testing methods have evolved with 
increased understanding of the factors in play and we have reported additional methods 
to improve this approach.  The experimental data in phantom and in vivo studies can be 
used to further advance the development and validation of electromagnetic simulation 
techniques.  Simulation can be computationally extensive and time-consuming as a 
result but also could allow investigation of numerous variables in a controlled test 
method.  Current simulations, however, must make many simplifications which can limit 
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their utility and miss important considerations.  With further development of this 
simulation data, the experimental data we generated and approach to dynamically 
evaluate measured heating will serve as valuable components in validating these 
methods.  Other promising approaches to reducing device and implant heating under 
investigation include parallel transmission and control of the B and E field distributions 
and device coupling which could help reduce heating potential (169).  More 
sophisticated monitoring systems building upon the one described in this work also could 
be implemented for normal device use.   
MRI guided procedures will continue to benefit from the continued work in real-
time MRI acquisition and reconstruction.  Parallel imaging with multi-channel coils and 
efficient reconstruction approaches can provide greater temporal resolution particularly 
beneficial for delicate cardiac procedures (170).  Improved spatial resolution would 
provide enhanced guidance for targeting procedures to small targets.  The unique direct 
cardiac access approach we presented requires a reliable percutaneous closure method 
for the access site whose deployment could also be informed by MRI guidance as 
shown with the demonstration of the VSD occluder apical delivery.  Selecting the proper 
targets for this technology is also critical for its successful implementation.  Many 
cardiovascular imaging techniques are available and constantly being developed and 
improved to guide less invasive procedures.  One must consider the features of each to 
determine the best modality for the desired procedure and the components that are 
necessary for its success.  Together, these can offer patients safe and efficacious 
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